var title_f26_56_27520="Buckle fracture radius ulna";
var content_f26_56_27520=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81117&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81117&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Distal radius and ulna torus (buckle) fractures in an 8-year-old child",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 446px; height: 453px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHFAb4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UoorU0vT4ru3aSRnBDY+Uj0HtQBl0VvnRrcfxy/mP8KT+x7f+/L+Y/woAwaK3jpFv/fl/Mf4Un9kW/8Afl/Mf4UAYVFbv9kW/wDfl/Mf4Un9k2/9+X8x/hQBh0Vuf2Tb/wB+X8x/hR/ZNv8A35fzH+FAGHRW5/ZVv/fl/Mf4UxtMgH8cn5j/AAoAxqK0zYRD+J/zH+FdNpPhCyu4kaaa4UnGdrL/AIUAcNRXqmpfD7R7Sy85Lq9dsZ4ljI/9BFcimgWrXhiEk20d9wz/ACoA5mivZbH4VaVcafb3D3WoAyAZw6Yyf+A1zXjHwVY6HMyQTXTgRhvnZTz+AFAHn9FdXonhy11AR75Jxux90j/CutuPhvpKW87xXV+XQ5UMyYIHX+GgDyeiuk1nQraxlVY5JmB/vEf4VRTToSeWk/Mf4UAZNFbQ0qA/xyfmP8Kd/ZNvj78v5j/CgDDorc/sm3/vy/mP8KP7Jg/vy/mP8KAMOitz+ybf+/L+Y/wo/sm3/vy/mP8ACgDDorc/sm3/AL8v5j/Cl/si3x9+X8x/hQBhUVYvoVguXjQkqMdevSm2kSzXCRsSFbrj6UAQ0Vs/2XD/AH5PzH+FH9lw/wB+T8x/hQBjUVs/2XD/AH5PzH+FH9lw/wB6T8x/hQBjUVrtpsI6NJ+Y/wAKW1023kuFSR5Ap9CP8KAMeivRNB8IaHdXkcWo3N9HG5xvjdBg9s5U11GpfCXR4YRNa3moMncO6E/ovSgDxOivYR8LdNkgBgm1B5MDI8xMf+g1j6z8Prayg8yCa6bnaQ5XKt6HigDzaitG7077NMUcOAD3pqWkR6s/5igChRWqunwn+J/zH+FOGmwf35PzH+FAGRRWx/ZkP9+T8x/hR/ZkH9+T8x/hQBj0Vsf2ZD/ek/Mf4Uf2ZB/fk/Mf4UAY9FbH9mQ/3pPzH+FH9mQ/35PzH+FAGPRWx/ZkP9+T8x/hR/ZkH9+T8x/hQBj0Vd1C2S28vyyx3Zzn8KpUAFb+gn/Qn/66H+QrAre0L/jzf/rof5CgDSAZ2CqCzE4AAySav+IND1Tw7f8A2HXLKayu9gk8uUYO09D9ODW18KjpEfj3SrrxFdR22mWbm7kZ/wCMxjcqAdyWCjHpmuu+NHifQPG2gaRrOm31zJq1tcTWs8N7Gkc7wsxkRgqsw2KSVHPfpQB5ITSE0hNJQAuaM0lJQAuaM0lJQApNRSN2p7VC5oAaAXkVR3OK9P8ABtqJ7mKMpuAUnb68V5xpMfnX6DsvNev+AovJledugGwfXrQBD4rs0h0ySfYFYNgbeOM4Nec6cfMvZW77gBXqfj+4T+wJlTr5i815j4cQSX4B6NLz9M0Ae76IqrpNpE4x5aKT9cCvN/i2ytqIKYw0OePqa72xusW2R1PArzX4jvvmjfI4Qj9f/r0AYPg6cJFEQcFT+VelS31s2nfLNGHI7Ic15T4MG94l6gyAfrXsy6eA5RkHlbdxUDtQB474qYFwR/erDRq3fGC+XMy/3XxWJBazOu5U4oAlRuKfmoCCjYYYI7GnBqAJc0uaYKWgB2aM02loAXPNLuptFAGHqv8Ax/Sfh/Kmad/x+xfj/Knap/x+yfh/Km6f/wAfkf4/yoA3s11J+Hvi3+xF1dfD9+2mtALkTqm5TERuD8c4wc/SuT96+m9P8WeE00jQbm71bRYkh8KxaVdzRSTf2lG3lHMUSBTHjcRyec7u2KAPmbPHSkLU2igBGNRMxVgV4I5FSGopBQB0OlX3nRgE4YdRXp/gzW2v4zpl05yqEo3civD7OUwXSMDwTgiu10i/ks7yC6gYrJEwYGgD163ZbGRbe5b9zJ80coH5/l6VoaloyahazDYhuFT51XkTR9mHqRUci22uaKvkEI06C4tzn7kg4ZfxxWd4c1qWOExSsVubJsoT3QnBX8D/ADoA8x8VaD5W7cpcH7rBfvD39xXndxE1tMUPTsa+kPFekR6tEZrNykEoLMi9Uf8AwNeNeIfDtysJljiYorbd2OjehoA5ZHqYNVQ7o3KSAqw4INTRtQBYBpd1Rg0tAD91Jnmm0UAPzRuplFAD91GaZRQBQ1g58r8f6Vm1o6v/AMsvx/pWdQAVu6H/AMeb/wC+f5CsKtvRP+PR/wDfP8hQBoE02g0lAC96Sg0maAFzSUmaQnigB1ITTc0E0ADGoJDUjHNQSmgDZ8MR7p3f3xXr/huMCxUpgYPcEc15X4SXMYPqc16ppcF5a6eksVwY1fkKV3D9aAMHx0zLp7qxB3MDwc1xPh1iswcdQ2a6Px79pjlDXcgdnTcCABx9KxfBtt9pu4IicB35PtQB6rpl9p5sQZLpEYLkhozXmvjq7S5mcxYMY4BAIz+deqi0RJBEiKFOMAjtXl/xHtktdRuEiAEbAOuPcf45oAwfA67rm2A7yj+de8+auDLxx8vXGRXhvgIf6TbtjO3LfjXrayt9hZQxxigDynxfGG1adT2nJ/Wreg2i3ETDGSOOKqeMXH9qyPxhnBrW8JjDu4PRQcevNAHNa7biOQsB904rJBrsfFlmqPNsB2Nllz6GuLU0ATKafmolNOBoAfS5pmaM0APJopoNLmgDE1T/AI/ZPw/lTdP/AOPyP6n+VLqX/H4/4fypth/x9x/j/KgDbJpM0UlAC0maTNGaAFNMbpTs0hoArv1yK6bSZhNAh7965p6vaJc+XMYmPDcigD2HwVqbC2gsmYna7FDnpnBxWhrkYt9R84Hb5wwxHr6159p1zJFKvlvtJrvobOTUbQl2drnbkZOd3tQBv2LpHbASzqjHj8a07nSbO/tPMMQWKYeVOijgN2YfzrjfDcyyyKuczx8BSeeD2/z2r023jW40yWaMDDIN3HfsaAPmT4l+HpNG1FyVxtOCR0IPQ1xsbV9IeO9IXXNJdHjJuoV+VsffXup/pXzlfW0ljePBJn5TwT3FAEqNkVIDVaJulWAeKAFopKWgBaKbS0ALRmkooAoat/yy/H+lZ1aGrf8ALL8f6Vn0AFbWjf8AHo/++f5CsWtrRf8Aj1f/AHz/ACFAF6kNBNNY0ABNN3U1jTSaAH7qQmgq4GSrY+lM3UAPzSimA0uaABqrSmp3OKrPywHcnFAHZ+Fo9sEA9cfrXtt3AVtbZVHGBke2K8g8Px4Nui/3lFe4S7RCgPDIABQB5L8WCI7q2TuIiPwyax/hwgbWLNT364+lXfi3Nv12QdliH+NVPhw3/E8s1BwcH88UAe1i2VrpPmICnbn8K8c+K7KNbmjXgJGB+le0iVQvHQMa8K+J8wk8QX5znB2/pQBmeD1dDA0QJfIwAeteqtfOtg2bOTeF52y9K4f4cQg30RKklFGPrXpccaIZXYZUfKR6+tAHiPi+VmlaQkkls81reGJihUqGPHRayPGy+XJKg/hfb+tbHgRTJMFPTy80AXvERMkZdkdcjgsc5rzw8SEehNeq+KbcR6ZEVOcPg+2RXldwNtzIP9o0APXpTwTUaU8UAL+NHfrQOlJQAtKOlNzQDQBkaj/x+P8Ah/Km2H/H3H+P8qXUf+Pt/wAP5Ulh/wAfcf4/yoA2TTaU0hNACE0c9gafbR+bNg9B1rft7MFPkQcUAc2WwelITW5eWakHcuDWLNGYpCp/A0ARN0otyVuYyPWg9KYTtYH0OaAOvtXLIMmvWfAdx9t0JJet1ZvsY92TqCf5V5BYvuRSD1FehfCy9EWrz2bHC3URAHuORQA/xbC+heIxc2w/dEidAO6nkj+deq+EruG43W8bZS6i3p+Iz/OuJ8bW/wBu0K3uMZktZPJf/dPSrPhed7W2sHjPz283ln/dzQBuasGa3ZY4A75MbZO3H414H8TNIa1uPMePy5FPI68fXvX09dQI2o3CFf3UyiZCOxNeSfGnTQ+j2lwo5JkiY47jkf1oA8DhbpVqM5FUIjg81ciNAE1FFFABRRRQAUUUUAUNV/5Zfj/Ss+tDVf8All+P9Kz6ACtnRv8Aj1f/AHz/ACFY1bOj/wDHq/8Avn+QoAvE0xqU01vpQAxq2vDtrHO+8gM2cAGsRq0PDt79lv1UnCv0+tAHdT6M8UIaSLCn2rl9c0UKpkgGG9u9ev2FxbajoUTMpJb5Wx2Irk9VsTA7ROPdT6jsaAPJslWIIwRTs1p+IrEwTmVRwetZAagBzmo4Buuoh6sKHNSache9T25oA9G8Jx+dqlnGOpkWvWLm7Rg4VvlznPSvMvBUbC7M2P8AVqcfU8V2bBjE4J644oA8u+KE+fEF6M5wFA/75FL8NWJ8QWfoCSfwFWvHlkjarLIw3CVFP6Af0qz4Ct1gv3m2jCIVXjueP8aAPUkvMxuvH3s9K8O+ITlvEF+D3mIr2JFDQgqcEZ69q8s+IVlv1u5kUECTEgPvjn9c0Aa3wy51CT0CV6UU8qJnDALtJ/GvMPhmSl9cbh/yz/rXo2oz+XaOxO0Kh/HjNAHhHjSUSzzH+9Kf510vgWMglx1AArjdfk824Qf3pM12fhCGU/vIiB5YycjNAG/4lQrp7KwIAIIyK8mv+L2X616l4mkmeCMyrGqlfl2DGfrXld+2b2T60ACGpKijqSgBaKKSgBaBRRQBkah/x9v+H8qSx/4+o/x/lS6h/wAfb/h/Km2P/H1H+P8AKgDZpjdKdTX6UATae+2f612uhFZE2nFcDG2yVTXVaHOyyjB4IoA0dYt1ALR8jOK5jU4CyEj7wrsXzIpLDcD1zWJfW+1mHb3oA5E0x6sXsfkzsOx5FVWNAG5o1xmALnleK6fQL5rPWrK4j+8kg/EVx3h6Dzrl8k7QOlegaDZRre27bRkMOaAO+t9Thvpri3cgRXSjOezdj+dS6cHgtrxCDuikUsBWf/ZpaRXRctj8q37aAiCUyDEjoqt7470Ad5ozC9s4JOrRIQT7df51wvxYswfCxyOPtBdfbIrrfBZa3m8iblWjYc+mKyvifZyy+DJtpBMEoc8dVoA+QLpPKvpk6Yc1NCelLrw2atNjvzUUBoAuDpS01TxS5oAWikooAWikzRQBR1X/AJZfj/Ss+r+qf8svx/pVCgArZ0f/AI9X/wB8/wAhWNWxo/8Ax6t/vn+QoAunrTG6U4mmGgBj1AWKOGHBByKsMOKrSUAeseBbxpbGSMvksFcDPfoa6PUrZ5bECRSShyvqP/rV574Au/KjjIJyhw2OuM16xcXv9o2IFrCyIvd+ATQB5dr1oJInBHJFefNlHZT1U4r1rWYDFvWUHfXmWu2vkXLSDox5oAos2a1PDsO+Zmx3wKxS1dX4Vi+RDjk80Aei+EIJBJiLHOAVK5zXfPpoe3LeRg46BsH+tcLoVs00iqrFOOWHaunl0tPKO24m8zsSePyoA4PxknmXe0IwMZwQ3XrmpPCy+W5Xy927GTuxinaxEfNO77ykhvrSaUsiTL5LEOSMGgD0SGwDWu9IpyuN3GP0PSvNPGiiW6ICuGXKncBn9K7c21+0IZtRnDEdmP8AjXFa5FL5ziZi0gPJJzn8aAF8CW+yC6lI5O1B+eT/ACrqtTYyWFyg6eU+CfXaaxPDMLC3VUGeSTzjn/Irdv4pEtyzR44xkHtjmgDwjU4mGo24bpnP5V6X4IiJ0uR1OCWx9Txj+tcfqdorXQHdWYA13fgH91ppVxyZMfpQA7xtH5WnWoPXkD17V47e/wDH5KPevYvHjZtrTB4y2BXj+ocX0v1oASOpahjNTCgBaSiigBaKSigDJ1D/AI+n/D+VNsf+PqP6n+VO1D/j6f8AD+VNsf8Aj6j/AB/lQBsU1+lOpG6UAQNW7os2dhzyKw26Va0ufyp9pPBoA9KsngW2zJ1x0zWfqEO4FxHtTscdaf4faORJGYbmXGB7VrGI3IdHXCkdBQB5trlvn5lH3awia7bVrbaJI2HI4NcRKpjkZD2NAG34UcC8kU9wK9F07ClT7ivK9Cn8nUU5xu4r03TpcxCgD1bR5bZLKNySXK9AKlijee+TEe1G4OR1ql4VKyWVs2ASw2j8K614SjoB2PJoA6HTraOONndlUohwSeao6zbi88O3sbncr27HOMZxV2xhUI692GcGrmoWyx6dOoKjFsePqKAPhDxjbPaa7JE45ArPgPPWu++NOnCDULa7QY3ZRsevWvPoDyKAL6Hinmooz0qTNAC0UlFAC0UlKaAKGqf8s/x/pVCr+p/8svx/pVCgArX0j/j2b/fP8hWRWvpH/Hs3++f5CgC0aKDRQA01BKKsGopBQBp+FL37LelGOFbmvofTHXUdGtLiFVWLhcL2x1/Gvl9HMMySL1U5r274S68GaTS5n/dXYDRZPCyjp+Y4oA0fGFiYokuAPkc7enSvLPEdr5kbjHOK9u1CSO8sprWddoPXjlT2NeVeIbOSB5YpFwynGfX3oA8wOd23vnGK7nw3EVRAOwrl2tD/AGlnHy5z+Nd9oNnIIgcLz0oA7bwtlg4OBj7zMcAV1iJEsJI3seDuIOPrXOeEoiwuYhxKAJFGOoHBH6ittYWaXaeX+tAHHa9bGC9kRzuJO7OOuaboce+8VcZb2GaveNNy67MmOEVVPtwCf507waA+pugA8xoyUz6jkj8qAOuS0DoPmAAGSpOTXAeIkzfS5RkHQBhgn3rs57pyV8wjHuM1zfi07pLdmBDPnj2HFAGbolx9jf5YDKT6HB/lV3XtX8+28p7Jom7Etn+lS+HbbexYAkjuBU3iSEx6c5kUDOAv1zQB5lfDNxn0NdtoG2PS4Y+jAF89wSeP0xXK3MBaUfrXZ+Hrbz4QfJcgjqH/AKYoAyvFrGSxhJ5KOQT9R/8AWryjU+L6THevYfFEISExmNl3c/Mf/rCvI9bj8u+PuKAK8ZqYGq8dTr0oAdRSUtABRRRQBk3/APx9P+H8qbY/8fUf4/ypb/8A4+n/AA/lSWP/AB9R/j/KgDYpDS0lAETdDUZJUhh1FTN1qJxQB1nhjUhDcRSH7h+Vx7V6C5VHJUgq3INeOaTNsmKdjyK9I0m8M1jHk5ZRt59qAIPFVsGlFxH92QYb2avOtcg2OJAPY16lcgSQNGw3Kw6VyN7pfnM6P90UAcjpkJeYSdNpyDXoejXHmQgHhhwa5aC3MFx5Lrg9PrW9YqY2Ur1oA9k+Gb/aWjiJz5Tlse2K9GdF3fdLEHq/+FeQ/DC6aPX4NpxuBGPU46V7bPCsiJMg+Vxn6e1AFqzWRiD5fueaXVJpZYblCIwGQqNvParGkr5trMuVEkYyM91qrdZRc7Rk+hoA+afjVYk2RBHK5YfhXiMB6V9MfGCz3F0Zeoz+Yr5nZDFO8Z6qxFAF6I8VLUEJ4qagBc0uabRQA7NGaSkoAp6mc+V+P9Ko1e1L/ln+P9Ko0AFa2knFs3++f5CsmtbSv+PZv9/+goAtmkoooADTHHFONI3SgCrIK6HwhqD288ZjbbLC4dD9DkVgyDipNIl8nUYznhjtNAH0PI/2x/tEOdsoD7R6EZrA8XWUjIrFCSF5IHQe9aPgfWIIYEF6CUVRjHJb29q0/Eou9XizDEtvbYGEP3j9cfyoA82j0OGexAYESE7gw7V02k2KRwqm3BUYxUsNm8EgjmQggcVfQBeB1AoAu+HQLbWLdj9128s/Q8V1ZgEOoop/v4P51xSuysCOoOR9a765xNcWs6/8tQj5+oFAHnvjpP8AipdRP/TUj9BWd4Yma18QabKvadQfoTg/oa2/HMX/ABUGocdZM/oK57SlJ1GzA6+cg/8AHhQB12uxmLU5IguFDkdenOK53xjhdZFvni2iSM49cZP867u8gW48TeW2MGTn6ZzXm2uTG51u9mJzvmYj6Z4oA6nQ41i0KCdQQHZtxVsHIOP8Kqa+3n6YS5yFGRnr9au6KAPCUXPWWTr+FZniT91paL0819o+g5P64oA44xb5MmtzTdOWSPfKzDPTFV9Fshd6jFCeQQzH8AT/AErrLdoSpRkUKg5wOR+XWgDjtXgeFyjuXGMqSe1eaeJlxdKR6mvUvEJC3kgwdqjC56keteW+J3DXigepoAzI6nHSq8dTigB1FJQKAFpaSigDJv8A/j6f8P5Ulj/x9R/j/Klv/wDj6f8AD+VJY/8AH1H+P8qANikNFHegBrDio36VIT1ph6UARI3lzK3oa7XQboD5S2FPNcTJXQaHLmJcHmgD02K2hS1Wa4k8tWGBn7zfQf5/Cs+5tozlokYIehPU07w9Ym7JllLSFcAKT1/+tXQS+UIjHKu6M8HH8PvQBwV9Zq5DY+deQaW3QBQcd62dUs/IfKneh6Gs8R4BwMUAdB4HlNt4n09s/K0wU/jx/WvorSyDbTwtyV+Zf6182aBkatZEdRMmP++hX0ZpsmLzb2cFaANDSGWO8XeQEbKk+mai1CDy5WXGNp5FNteZnU9e1X55RPCrH7wADUAeS/GK1JsbecDqCpI9v/118p65H5OsXAHc7q+z/ihYiXw65C/dO4fSvj3xnF5erBv7y/yNAGfAasiqcBq0OlADqKKKACiiigClqX/LP8f6VSq7qP8Ayz/H+lUqACtXSv8Aj2b/AHz/ACFZVa2lf8ezf7/9BQBaooooAQ0GiigCGTpVfcY5FYdVOatOKrSjmgD1nwLdpcS2oJBXcpOfSvYJjAI1lQqUIxtHXNfNngjUWtrhcNyjA19B6W0VzAjjLRSoJFPoe4/QigCtr8H+hR3CJwGGWAxkHjn9KxQM/hXb2UUV5HcWLnEdwhUZ/hbsfzriWR4ZZIpRiRCVZfQg4oAFIzjvXdWD+ZomnS91XZ+Rrh0UM2P1rtNJxH4YhyeVlbH0zQBzvjiM/wBuyyDpMiuD+GP6VheHLbzfEFmmOPODfgOf6V1vi6AXNhaXcYBKEwv7Z5B/nWX4TiEWpyXUg+WJcD6n/wCtQB0MLbvE7NnpuP44ry6b5ppTj+I/zr0C0uc69uyCCcce9cjb2RudWMHTMpDH0APNAHSWUZh0OwgAJJUuc+rHNZHjZh/aMdsp+W2iCkf7R5NdVbKtxqEEeAI1YDHsK4XWpTdandzv/HKzD86ANDwRalpb27YfLHHsUn1b/wCsKWE7TKTyfWtnT4Dp2gJERiaUeY49z0H5Vi6ov2LTN3HmzfKMdqAOQ1y5M08smeO1eZ6zJ5l8fau+1p/Lgb6V5vO/mXUje9ADo6mHSooxUooAdRSUUALRSUtAGVff8fT/AIfypLL/AI+k/H+VLff8fT/h/Kksf+PqP8f5UAa/pSUtJQA09aQ0ppDQBDIK0vD8224KE+4rPcdaWwfy7xDng8UAev8AhS8aFyIyN5AwDWtdxSLukIJJ+99PWuN0S4K7HU4IrvbdvtVmkiHIxj/61AFKO0W6tmiJ+Yg49j2rnJIzGzI4wynBFdUAYznnae9ZmuwK4W6iHbbIB69jQAzwwu7W9PB/57p/MV7zaSFb2Mg/x14X4PXd4gsQe0gP5c17XA3+lQjsWH86ANsuYb/IP8X51fxj7v3XU1l3zj7SSD34rSgcbwvYIsgPsRzQBl+M4ftHh1wBnKFT9cV8Y/ESDy7xT3DsK+2tUXzdGmUcjOa+P/ixaGK4lOPuyf8A1qAPP4DVxaowGrsfSgCSkoooAWikpaAKWo/8s/x/pVKruo/8s/x/pVKgArV0v/j3b/eP8hWVWrpf/Hu3++f5CgC3SUtJQAUlLSdqAEbpVeUVYNRSCgB2jz/Z9RjOcBuDXvvw41NZo/sMrfeG6E+/cfj1/Cvnd+GyOor0PwVqzbYnR9sqEHI7EUAe5SAxSiZWwwIJx2qj4kiF241KEDzDgXAHr2b8e9W7e7i1TT4rqPALDEij+Fu9NiDRNkDKngg9x6UAc5GDxjOa6xG8vQLaPvgsR9TWLfWf2eXdFnyT/CT932+lbFvLv06NSvIG0+/+cUAFsv2i0uLSQZEinHsRgg1mafEY9OmGcNvw9asAK3EbjNMMSwzXSqOGPmp/UUAZESAXCOByCD0qG0h2X97MqjLyEL+PNajwlVJOAe3NVtPwY9vc5Y+/b+QFAEmlylb4ufuhW6/SsPSNPWWfzrgZjTLKvdj2/Cuht4A0pjQEbgcnPGKpTkRxMkfBz+ntQBPLK13cRqCOoGMVzHiecT6hJGjZjgHlr6EjqfzrbhnNurTf880JyfXt+tchfSFYmLdTkk0Acf4quPLgcZ5xXBp710Hi278yYRqep5rBQUATJ0qSmLT6AFoo7UlAC0UgpaAMu+/4+X/D+VJZf8fUf4/ypb7/AI+X/D+VJZf8fUf4/wAqANbNJSk02gANJRRQAxqhbKtkduRU7dKicUAdh4duw8S89a73Qr0W8yiTmF+HHp715BoV39nuBGx4PIr0PTbkOi80AdxqMW3IU5U8gjuO1Y7HBZWxtbgj1q3p155tqIpG5j+7k9vSm3FszzHy1J749KAE8JW5i8QwAHKjJU/hXrNic3cBJ4BzXnvhq22ahuOWKjqBwPxru7dzHIr+lAGrdyESbia2rJhICemyIr+FYU+GUMOhrW0xyElyMBlP4UAI0paxnBznrXzN8aLT9/eEDuSP519Hbx+9Xn5uvpXhXxYiEzTHHJXn69P6UAeAQmr8faqEY2uR6HFXYulAE1FFFABRRRQBT1H/AJZ/j/SqVXNQ/wCWf4/0qnQAVqaX/wAe7f739BWXWppf/Hu3+/8A0FAFuiiigApKKQ0ABpjCn0hoAqyCreh3ps71cnCMcH61C4qs4oA968F6wEDRMw8uUDj0YdDXoumLDMoaRgX6kA9Pr7185eENXICxyNhl4NeueHtZMUeAA6tzz60AdnqkEc0LFchE6dhms2IyRqEjx16GpLa6k1GZY2YKnXA6AevvW0bW3Cr5YGOmepFAFBRNsyAj4GcDg/hVK4kmurlDCpVl+6B+ua2FAMa4OMHrmodPRVMjY/1zHB74zQBnXNtdMm1ygJ4ziqlqHt90axb2XjiujukXOATux0zmq8cW0Ar0JwTigDLgnfe6yL5bMPlGME+1UZYw8jA5xnPIrfuVLxFWUcDjiuevpnR2AwDjrQBQ1e4jWP7PASQD87Y6n0ri/EN0IoX55xXQai/lqST17mvM/GGp5LRofmPAoA5e+mNxeO+cjOBTYxUSCrCCgB6+1LQOlFAC0fSikoAWiiigDLvv+Pl/w/lRZf8AHyn4/wAqL3/j5f8AD+VFn/x8p+P8qANSig80lABRRRQAh6Uxh1p9NYUAQNlWDLwR0rsPDmoCWNQT8w61yTin2Ny1pcBwTtPUUAeuWc3Rh19K6PT7vz4dq7FI7E9K8/0jUFljQhgQa6OzO5lHXPegDvtAUR+Yxbc7+/SukjPyjNZHh23jhgQ43NjPNb0rr5Z4oAmhml8nGFI7E9atWd1MqN8ufc1UtJBImM8jtVmLbtZiDle2aAI7yVgjSYJwM4zXjvj5zOkrv1Oc16/fz7YeMAfSvKPHy5ikcADOcgCgD54nXZdzL6OaniPFJqa7NTuB/tZoioAsDpS00U7tQAlLSCigCnqH8H41Tq5qH/LP8f6VToAK1NL/AOPdv97+grLrU0v/AI92/wB7+goAt0UtJQAlJS0lABSGiigBjVC61Yao2FAEMM0ltMJIzgj9a9C8Ka+JUUFvYj0rzyQVLpVw1rfKQcKxwaAPobSNV8qRHVs9vrXTDVRLCVjOCRjJ7V5Lo16XtV55Fdz4Uuw9yBLg+mR3oA20kbG3cdo7ZrasmTYgHOF9KgvPJmik24BUEg46VQsrh48IFz6Y7UAbd2QI3fPQdfXinQ7RCuOijOT/ADqnO8k0WxcDPX3qtAZp3FuXKr39hQA+9vJJ3Mdgm7H3pD0/Cufv7aSEsXOSeSSc13Krb28ISFACO561yniNwM+oBJoA8/8AE1z5UbkHHFeM39y13eSSEnGcL9K9G8b3DC1nwfmKkV5hEOKALEYqdfpUMdTigBRRRRQAUUUUALR1oooAy73/AI+X/D+VFn/x8p/ntRff8fL/AIfyosv+PlPx/lQBqUlKaSgAoopKACkNLRQAwionWpyKjYcUATaXqLWUoDEmIn8q9I8O6ik0sPzA5I59a8olFavhbUXt7+KBmOxm+X2NAH09pFyVjXvgVpea78k/QVyvhy7E1rGc/NiultZE8xd2MUASxyvEwYZ61qWs+1mzyGHeoSFkXb1z29KqQuY51WTJX1HtQBPqWSGK5K49K858ayrNEyRjhQSx9TXol9N58RA4X271wXiy3VVfH8S80AfPOurt1aX3wahiNXvFKeXqp91/rVCI0AWV6UtIlLQAUGikNAFO/wD4PxqpVy//AIPx/pVOgArU0v8A492/3v6CsutTS/8Aj3b/AHv6CgC3RQaSgANJS0lACUUGg0AIaQ0tJQBDIKrPkHI6g5q3JVWSgD0PwtN5kPXqAa9A0aMnbj14xXmfglt8Uf0xXr/htVW4T5ctj5frQBqiC8CjzEm8vuSCR+NPTCsDzwe1dNYGRW3REhj19/rWp9ljnjzdabE7Y6oNp/SgDGspFaEEMG45IrK1OYQ3ayR4Lj72K6S60OybOzMLf3Q6k/zrmNQszazGMNvXqCev40AIdbXaVCMXHr2rm9bvmlV88seprR+xzSuBFC7sePlGar3Wh3ABacrHnjBOT+PpQB5R4wBeCUEdVNecxdK9X8XW/wC6ccHrXlC8Mw9DigCzH1qbtUMZ5qagBe1JRRQAtFFFABS0lLQBl3v/AB8v+H8qSz/4+U/z2pb3/j5f8P5UWf8Ax8pQBp0UUUAFFFJQAUUUlAB3prDinU1u9AFaUVJo6b9Vg9jmo5a1PClqZr1pMfd4oA9f8K3jRQorHK4rtYbtSAM1xGjRlIxx6V01sfug5zQB0FpPIzlULEYxnsK01VlA8yPHsRwadpEIltUWOPfgcqBz9cVoJbnaVMcpX+7g8UAY13NbxjgjjkgVyGuv9o3OeARjHoK63W7BICGhRwp6qe1cjqnEbUAeEeOItmoRkd8isOKum8er++VvRzXLxHpQBbWl7U1egp1AB2oooNAFO/8A+Wf41Uq3f/wfjVSgArU0v/j3b/e/oKy61NL/AOPdv97+goAtmkNKaSgBKKKKAEpKWkoASilNJQBHJVaSrMnSq8negDs/AXKR/U/zr2Xw/B51xGikjPJb0FeNeAf9Wn1Ne1+GCEvIXPQYz7g0AeiWCxrCo82ZgPU1cMVtIhDRK49HJNZlov3gexxV/hV5B9RQArR2nl7WtLfb7IKwtcsIEAlthsBOCnb8K21+aPp+tYWvysoiRSeTmgCbTLO9WFV/cpHj+IEn8qj1nTpLiIq06p7hOv8AhVnSrszWykk7hw3samny4PpQB4j43sRAHTO4YyDjFeHzrsu5l9GNfRPxGgKsCe6f1r5+1mPytWnHqc0ARxmpxVaM1ZXpQAtFFFAC0UUUAFLSUUAZl7/x8t+H8qSz/wCPlP8APalvf+Plvw/lSWn/AB8p/ntQBqUUGigApKKKACiikoAKY3en1G/egCvKeDXYeBYMxBsfeYmuOlr0XwHB/okJI7ZoA9A0uIYXIrpNJjDXCDFZ2nRBVBHoK2bAbLuI9gwoA6u3iiWMbk985xitGzRCct57DtiQjFZzJhBkYNX9NfEPf5Tjn0oAh1WzVUeRFmYYLddw/GvL9ab7/G3k8elerXt0BFcBcfKh59zxXlvic5u5goHb+VAHinjtchiezA1yMXvXZ+OBmKY+n+NcXFQBaTpT+1MTpT+1ABRRQaAKd/8A8s/x/pVSrl//AAfjVOgArU0v/j3b/e/oKy61NL/492/3v6CgC3SUtIaAEoopKACkPWlNJQAUhpaSgDol8DeIpokkj07KOoZT58fIP/AqifwB4mP/ADDf/I8X/wAVWA9VpKAPob4X/BLXdQ8KRaot3a290ZXVrSfsAeCHUsDn6Cusn8N6r4cYJqsCxngKyyqwb8jn868L8BeNvENhox0Wy1e6tdNSRnEMD+XktyclcE/ia9O8P3DzAPI5d25ZmOSaAPVLdgV47gHNThlYEHOT6HGKy9DkMunqT95CUP8AStBVwPegCVQdoBx045rnfERHmxKDyAc/nW+FzxXO6181/KP7uAPyoAXw65Ny8JPEi5H1FbLMBx29a5aB2t5lkjOHU5GK7O42vFHKAMSKH9uRQB578Q9OM0dqxZU3kx73OFB68msXw9+zwniu8F5ceLtLEO0FotNIuXx7nICn8DXa+OoBL4ackZKSAg/pXzT40aayuYLq1lkhmjf5ZI2Ksv0IoA2/G/w5t9B8X6ppdl4g0hba1l8tBeXgWbGB98BcA1kr4R4/5GHw7/4G/wD2NcpcXlzf3Ul1fXE1zcynLyzOXdz6knk09OlAGrrWlf2U0S/b9PvfMBObObzAuPXgYrNpKWgAooooAKWkpaAMy9/4+W/D+VJZ/wDHyn+e1Le/8fLfh/Kks/8Aj5T/AD2oA1KKKSgA7UUUUAFFFJQAVHJ0qSo5OlAFWWvUfAHz2cP+6K8tlr1P4b82MOf7ooA9R09cRDA7VpW/yyoR13A/rVHT1/diro4YH0NAHXyg5yF9ealsI3l81d2FABzTbjhC3YgH9Km8ODfeTK/K+WWP4UAUdYaOGAQqcyykMc9lB4rjW0c6xq1xCL6xs/nxvu5hGtb94WmuTIWJcnA9q5PxZgXkwXqMZ+uKAOssv2ddM1RBNruuz3EMnOywVUBH++27I/AV3/hn4OeA/DgRrHw7aTTL/wAtrwG4bPr8+QD9AK+RtT1/WdAlnm0PVL2wkwTm3mZM/UA8/jWz4V/aS8daVsTU5LLWIRgH7VCEfHs0e3n3INAHX+L/AIDrqXi7XL+PxjoFol1fTzrbu2GhDSMwQjPBGcfhWT/wz1/1PXh3/vv/AOvXjHiTVm17xLq+rvCIG1C7muzEG3BDI5bbnvjPWs+gDv8A4ofDj/hBINPk/t/TdW+1s67bNsmPaByee+f0rgKKKAKl/wDwfjVSrd//AMs/xqpQAVqaZ/x7t/vf0FZdammf8e7f739BQBbpKWkNACGg0UUAJ3pKWigBKKKSgBG6VWkHWrLVBJQBf8MybL11z1ANe0eFJgVQE8YrwzSZPL1GM+uRXrnhK5/eRgEZJoA9n8Hvva5hJ+8ocfhW9swTjtXI+ELjy9Whz0fKH8RXaSIUlI7ZoAjRMuM965fVSTqFxyPvGuxjQFh9a4vUv+Qhcc9GNAFNx6V2EJL6TYt/sbT+BrkDwD+uK6rSzv0CHvscrQBR8UR+Z4YviBkqVOPxr5n+IUX+iyHH3WBr6l1CEzaDqUYHPkkivm3x7blrG6GOdpNAHl8VWo6pwmrcdAEtApaSgBaKKKAClpKKAM29/wCPlvw/lSWf/Hyn+e1Lef8AHy34fypLP/j5T/PagDUpKWigBKKDRQAUlLSdqACo5OlSVFJ0oAqy16t8Nxmxg/3RXlEpr1j4bf8AHjAP9kUAerWYwin1qy4waq2hwi+lXW689KAOtk+ewgkH8US/yqz4Yz5t4+c4gaqlp+80C1b0Qr+Rq/4cGLbUWx0gNAHORjdcKMcA1w3iCTzLq5c85dv513Vr/rQx7159qxJ80+pP86APMPFvPn/7p/lXnsNegeKuRceuD/KvP4aALUdSUyOn9qACiijtQBUv/wDln+P9KqVbv/4PxqpQAVqaZ/x7t/vf0FZdaemf8e7f739BQBcpKWkNACUUUUAJSUtIaACkpaSgANQSCp6iloAgify7iN/Rga9L8Nz7JEIPevMZO9d34bl3LCc9QDQB7Zo1xsntpRnh1P616vcp8yt2IzXjGkvvtoyucjFez2zCfTLOXrujFADoE5/WuD1T/kIz4/vV6FAvJ+lcBqw/4mE/+8aAKJrp/Dnz6NOn9yXP5iuZxmuj8IEMt/D6oHH50AattFvt7iMj78bL9eK+dPGlrlbiMjsRX0npwzLjPByK8H8e25i1G7THAdv50AfPMY2sQe3FW4j0qK9j8nULhP7sh/nT4jQBY7UtIDxS0AFFFFABRRRQBm3v/Hw34fypLT/j4T/Palvf+Phvw/lSWn/Hwn+e1AGpRRRQAlFFFABSUtJQAHpUT9KlqKTpQBUlr1f4dnbawr/sivKJa9X8BjEaD0UUAeq2n3Fq4T0NUrX7i9elWqAOx0Yb/Dqf7LsP1rT0FcaZqjAf8sT/ADrL8N/N4emHcSGtjQFzpmpj/piaAOWtF5b/AGVJrznU+j/jXpNqMpL7xtXnGoLlGHPegDzHxQpJn9wf5V57FXpPiZMySj2rzZOGPtQBajqSo46koAKKKKAKl/8Awfj/AEqpVu//AIPxqpQAVqaX/wAe7f739BWXWppn/Hu3+9/QUAWzSUtJQAGm0tFACUlLSUAFJS0lAB2qOQcVJTHHFAFWXoa6rwtL/o8XPTiuWlrf8KNmPb6MaAPbvDr77NO3Fe0+GH87wxbnqU+WvEfCZLWSH8K9m8Btv0W4j/uOevvQBs2w/eAe1cFrCY1G4H+1XfW/+tHvxXE+IEMepzds+9AGOowRW54QO3VzGf8AlrEy/jjP9KxQD1zWloEgg1mzY4x5gU/Q8f1oA6qy+W6UcZzXkHxQtvL1q74xubP517DcR+TqJXph685+LtsBqDyAfeRWoA+VvE0Xla5Pjo2GqpEa2/HcPl6lHJj7ykflWFF2oAtr0p1MTpT6ACiiigAoopaAMy8/4+G/D+VJZ/8AHwlLef8AHw34fypLT/j4T/PagDUooooAKSg0UAFJS0lABUUnSpD0qKTpQBWflgPU16v4J4ZR7CvKoxuuIx6sK9X8Gr84/CgD060OFX6VcBOetU7T7g+lWx14oA7Lwj82jXa/7Wf5VueHlP2PUR2MLVheCjmwvB7/ANK6Lw4P3d8nrE1AHJWmP347iNq85vR1r0aEFbmdeeY3rzu7B2mgDzvxMn71j7V5g42zyD0Y16t4oT58/WvLbwbb6Yf7RoAfHUtQx1NQAUUUUAVL/wD5Z/jVSrd//wAs/wAaqUAFammf8e7f739BWXWppf8Ax7t/vf0FAFukpaSgBKQ0p9qKAEpKWkoAKSlpKACmPT6a3SgCrJWz4UP7yRfRhWPIK1PCxxdSD6UAe5eC/wDj0/GvYPhy+WvITzlQa8e8E8wkV6v4Al8vWNp6OhH5UAdYq7Jh7c1yni2PZqG7HDCuymXbMw9DXM+M4h+6f3oA5Ij5fepon2NG46qwb8jTSBSgDGKAPQtXUG4imHSRVcfiK4f4sW4eKCTH3ov5V3BP2jQtMnzljFtJ9xxXOfEKES6Nav6ZUmgD5N+ItvhI5Mcq/P41xsJ4FekfEK33WU/HK8/lXmkJ4FAF1DT6jjqSgBaKKKACigUUAZt7/wAfLfh/KktP+PhP89qW9/4+G/D+VJaf8fCf57UAalFFFACUUUUAFJS0lACHpUUtStUEvegAsxuvYR/tV6z4NTk/hXlWlLu1GP2zXrfg9SFJx3oA9Bs/uKatkfnVa24jHerIwQaAOx8CcwXa+v8AhXS+F1zcXa46xMK5jwAebkev+FdZ4WX/AImE49UagDj9pGoTY/55tn8q85uuh+tenOub+b/davNLoHDDHc0AcH4qTHPHevKtUG3UpfrmvW/FS/KTjvXlGtjGot7gUAQx1MKgjqagBaKKKAKl/wD8s/xqpVu//g/GqlABWppn/Hu3+9/QVl1qaX/x7t/vf0FAFukpaSgBKSlNBoASkpaDQAlBopKACmuOKdTX6UAVpK0fCx/4mDj1A/nWdLWj4VGdUI9v60Ae6eB+Ex6ivTPCknla1atzyxU/iK808EL1AHQV6Fpj+Td20nOQ6n9aAPTbwYuD71geLY99gGxyOa37nlkbrlRWdrUXnWDr7GgDz4jBOeM0vOfwpduDg0dwaAO70I+d4PhOcmKVk+lZvi+LzfDJOMlJAaveCz5vhzUYv+ecoYfiKTV4/O8OXq55VdwoA+YvHVsGjuk29QeK8Zi4JB617542h/fS/wC0M14POnlXkyf3XIoAnjqYVBFU46UALRRRQAUUUtAGZef8fDfh/KktP+PhPx/lS3v/AB8t+H8qS0/4+U/z2oA1KSlooAKQ0tJQAUlLSUAIelQSd6nNV5O9AFnQxnUR9K9d8IL+7Ax1NeTeHBm+c+g/rXsHhBfkX60AdzAP3QqYdKZAPkGalxxmgDrfh+f30/1B/Sux8MAf2rKBj7hrjvh/xcXGenH9a7Twpg6vL/unigDlWH/Exm47PXmN2MF/qa9T2j+05/Ub+Pzry67Hzt9TQBxfihcxMa8l8QDGoD/dr2DxOP3L/SvIvEgxeIfY0AUY6mFQRmpx0oAWiijtQBUv/wCD8aqVbv8A+D8aqUAFaml/8e7f739BWXWppf8Ax7t/vf0FAFukpaQ0AJQaWkoASiiigBKSlooASmv0p1NbpQBWlrU8IDOr/h/WsqWtrwQm7VHPoB/OgD3TwSp3OTxxXbDKgY6jmuS8FJw59K7Dbx0oA9Lik82xt5Ou5AajuAHide2DVbQ5PN0G3J6r8v5VZBHI9qAPPryPy7qVfRuKiOD9a1PEEPlX5OPvCswAZoA674dHeurQesQYfrWgieZYX0R5yhrL+G7Eazcx9pICPyNbNkP9ImU/xAigD558cQ4bPcgjmvANdj8rWbgerZr6S8fW+13B/hdh+tfPHjGIx6ySf4lFAGdEasjpVWKrKcigB1FFFACiiiigDMvP+Phvw/lSWf8Ax8p/ntS3n/Hw34fypLP/AI+U/wA9qANSiiigApKKKACkpaSgBrVXlqw1VpaANXwsubiRvoK9h8JIdi/WvJvCUed7erYr2PwjH+7WgDrox8gqXbhDnvSIPlHb3qYghaAOn+H4/wBJn/D+tdj4Q51mbp901yHgIYmuifQV1vgn5tWuD7GgDBC/8Tef6v8A1ry28Hzt/vEV6qOdXn4P8f8AWvL7tcyS/wC8f50Acf4lTMD+wryHxSuJ4j65r2bxGv8Ao7/SvHvFi4aM/wC1QBjR1OOlVoqsr0oAWjk0UUAVL/8Ag/H+lVKt3/8Ayz/H+lVKACtTS/8Aj3b/AHv6CsutTTP+Pdv97+goAt0UUlAAaSlooAbRRRQAneilpMUAJTXp9MfpQBVlro/ACZv5j6YrnJa6r4dLmec/7QoA948FR/uXNdUB/Ouf8Gx4syexNdKBwAetAHU+E336bPFn7j5/OtEkhhWL4NfbezwnpImR+FbsqYbHegDn/FUXypLjp1rm+eOciu11mLz7Jx3A4riyDyD1oA6L4eNt8Tx/7UbD9K6GAbdRYds1zPgUlfE1r9GH6V0jnbqR9A9AHkfxKg2XV4OOHzXzb49j238LnuCK+p/ijBi9ueOGUNXzJ8Rkw8LejkUAcpFVpORVOHtVuPoKAH0tAooAKKKKAMy9/wCPlvw/lSWf/Hyn+e1Le/8AHy34fypLP/j5T/PagDUooooASilpKACkpaKAI271Wl6GrL9Kqyng0AdX4Oi/0dT6sTXsXhWPECmvK/CcW23hGP4c17B4cj22yDHagDoEAwDipWHy0kajaM4p0nAoA6bwLw919B/Wup8B5/tO5PtXL+ChgXh/2f6Guu8DJi7u27AUAYS86vdY6gvXmNwuXk9Cx/nXp0XOs3v/AAOvNXGWb6n+dAHK+IV/cSZ9K8d8XLhVP+3XtPiAfuX+leN+MF/c5/2xQBzUXarK9KqxdqtL0oAWijpRQBVv/wCD8ap1bv8A/ln+NVKACtTS/wDUN/vf0FZdaml/8e7f739BQBbooooAQ0UUUAJSUtFACGkpTSUAFMk6U+mSdKAKkveux+G6g+efV8fpXHS13Pw0X/R5D6yUAe/eEUxpy/nW/gY4rI8LriwTjAxW7tz9KALOiSi21a1cnALbT+NdleJtdiPXNcIwK4YZypBFd/uFxYW8453rz+VAGbONyup7jNcTeR+XcyIeMGu4n4APoa5XX4fLvs44YcUATeC+PEtqSOcn+VdLdfLqDHvvrmfBgP8AwkVv+JrpdQ5umOepoA434ow/6Tkfxx18vfEqP9xnHKyCvq74lx7obWQjO5CP0r5g+JcX+h3HH3Wz+tAHmsJ6VcjqlD0q5FQBLRSUtABRRRQBmXv/AB8t+H8qSz/4+U/z2pb3/j5b8P5Uln/x8p/ntQBqGiiigApKWkoAKT3paRulAEbniqrjcwX1OKsydKZZIZL+Ff8AazQB6L4bi2hAOwAr1nRU2wrXmvhqHc8Yx3FepaauI1xQBqIMLSt0oQcUp5oA6bwXyLsD0/pXaeC1wLtiOua4vwSMtdj2/pXc+HMRWjEfxsFNAHMJxrN5nsHrzXrn616a4xq2ok9g38q80xQBzviBf3T1434wX/RnPuK9q19f3L8dq8c8YL/os3HSgDjYqsp0qrFVpOlADqKKWgCnf/8ALP8AGqlW7/8Ag/H+lVKACtTS/wDj3b/e/oKy61NL/wCPdv8Ae/oKALdFFFACGilpKAEpKWkOaACk70tFACVHJUtRS8UAVJe9eh/DSP8A0AH1cmvO5ulenfDVMabCc9cn9aAPevDaf6AnpgVuY+Wsjw6MWaD2rbVc9qAIWGa7DwtL9p0aSAnLRHA+lckw5PFbXg+58nVDG33ZVx+NAGhNzuB6g1ieJYd1rFN3VsH8a6HU4vJvWXseKzb+I3FhPGRk4yPwoAx/Bg/4n0ZHZSa6K9P+kk+9YXgpc6u79ljIrauj++J980AZPxCTdpVmw9cZ/CvmX4kwZtbwY5wTX1J43XfoUJ/uuP5V84fEeHMdwMdVP8qAPDYKuxdKoQ8cVeioAmFFApaAEpaKKAMu9/4+W/D+VJZ/8fKf57Ut7/x8v+H8qSz/AOPlP89qANSilpKACkpaKAEpGpaa9AEMh61a0CPzNSB/ujNU5Sa2PCcW6aV/UgUAeneFosspA6V6NYrhFxXEeFouM9uK7u0GFX0xQBdTGKU0q8LSEdaAOj8FH97c/QZrvLf9xa2yj7xbPNcD4G+a+nQdSBXeao3kyW6dwAfzoAwrxNmpakfr/KvL8ZHFer64uy+vSP4lz+leWAfKM0AYmurmBvpXjvi9M2tx9DXtGtDNu2B2rx7xamYLgf7JoA8+iq0nSqkR4q2nSgB9FBFAoAqah/B+P9Kp1c1D/ln+P9Kp0AFaml/8e7f739BWXWppf/Hu3+9/QUAXKSlpKACkpaKAEpDS0UAJSUtFACVFL0qaopaAKcvevVPhwv8AxK7b6f1ryuXvXq/w1wdLtvpQB7z4fH+iL7AVuoOKwtA/1C/QVvp92gCFl5NFtIbe5jlX+BgalYdcVG65GKAO31xBLBb3C87lAz61lW43SFD0bir+kSG88OBCcvEcflVFvlkXIoAzvDUBt59QbGNj7P8AP51ckILEk8VemthBE8oHE53/AKVnMcqeOhoAb4uUN4bBGcCRf6189/EOLKy8Hla+ifEg3eGGwOjr/OvBfiBH8p44xigD5tA2zOPQkVbiqvOu29nX0dv51PDQBZFFA6UUAFFLRQBlXv8Ax8v+H8qLP/j5T/Palvv+Pl/w/lSWf/Hyn+e1AGoaSnGkoASiiigApj0+mPQBWkrp/B8f7lTj7zE1y8hrtfCMeLaHjtmgD1DwzFiEHHvXY2w/Kua8Px4gSung6D2oAtKMj3obOPalUcd6U9Oe1AHSfDiPzNfZO23J/Cuv1192okf3SAPwrnPhZF/xOJ5T0Ee0VvaqSdRY9fmoAh8WAJPIw/igDfpXlePlFeqeMuAp7fZ/6V5dt+XmgDI1YfuG9a8i8WLlLgexr2HVeYH9cV5J4pXif8aAPLoatJ0qrEOatx9KAHgUtFFAFPUP+Wf41Tq7qH/LP8f6VSoAK1dL/wCPdv8Ae/oKyq1dL/49m/3/AOgoAt96KWkoASilNJQAUlLRQAlFLSYoASo5RUtRSDigClL3xXqnwxbOmQe2R+pryuXvXp/wtYHT4x6MR+tAH0DoH/Hun0FdEi/KM1zfh45t4/8AdFdNGMAUAIU6g1GyfjVgjnFRkZJoA2fBswE9xbE8SLkfWpL1GSVgexrK0qb7NqkEmcDdg/jXUX1r5moRADhmz+FAEuqwFdFtyv3ogCc+h61ziDKH611V5MuXR+UIKkVzLRmGWSMjkHj6UAO14E+FXPcMo/WvD/HseYAe9e666P8AikpMd5F/nXi3jlB9m596APlzUV26rdD0kb+dPhpdbG3Xb0f9NTTYaALI6UtA6UUAFFLRQBlX3/Hy/wCH8qSy/wCPlP8APalvv+Pp/wAP5Ull/wAfUf4/yoA1sc+9J0NOpCKAG0lOxSUAJUb96kqOSgCrL3r0LwvFiKEegArz1xlsepr07wxHzGPoKAPTtFXbEtb8AwKyNLXEa46VtRD5aAJ0ND/dOKReDip7aE3N1FCM/MwB+negDufh9H9leAEYaUFjWhqOPt49CaqaA2Neto04VRjirmqgC63ZGc0AV/HH/IPtpOxhYZrzNxha9P8AGH7zwtbyk8qShP1//VXmbjC0AY+qg+S3HavJfFIH778a9c1QYhb6V5J4o6y/jQB5Un3j9atR9Kqx/eP1q0nSgCWiiigCnqP/ACz/AB/pVKruo/8ALP8AH+lUqACtbSv+PZ/9/wDoKya1tJH+jN/v/wBBQBbpKcaSgBKKKKAEopaKAEooooAKil6VLUcnSgClL3r0b4Vt/ogHXDnj8a85mr0L4Vn9wwx/y0NAH0N4ZO6BPauriHT06VynhXmBe3NddAPlFADtvX1qMjHWpwDz6Ux6AIHGOR1Feg6ZtubW2ujgkRY/GuAau18IPv0Qg/wOy/oD/WgCC/ciU4xwaoXaltkh+8AAcdxV3UFzK2SM5quF328gPpnj1zQBHruP+ESUj+KUfzrxvxqg+yNkfjXsniAf8Unbe8v+NeReM1zamgD5T8RDHiK+H/TQ1DDVnxRx4m1Af9NP6VWh7UAWh0paF6UtACUUtFAGTf8A/H0/4fypLH/j6j/H+VLf/wDH0/4fypLH/j6j/H+VAGvRS0lACGm0/FIRQA01C561ORgVBJ0NAEUI3XMS+rivVvC0eZEJ9a8v01N+pQD/AGs1674UiO5OOKAPQtMXEa1sRDis2wUhFHtWpGDtoAU9QPet3w5BmWScj7q7V+tYZHzKMV1+nQ/ZrKNT1Iz+dAF7w4x/t+M+xrT1Mgyjd65rI8Ott1iJsetat2S8mcZBOB7UARa0RN4Smi7qRIPzrzmReO3NeiXRwvknGxl2H8RXAXEZjcqR904oAwtWH7lvpXkPik4838a9e1jHkt614/4rPyTfQ0AeWxj5j9atx9Kqw1bToPWgB9FLRQBS1H/ln+P9KpVd1H/ln+P9KpUAFbGkf8ez/wC//QVj1atryS3jKIqEE55FAG0RmkIrL/tOb+7H+R/xpP7Sm/ux/kf8aANPFGKzP7Sm/ux/kf8AGk/tGb+7H+R/xoA1MUVl/wBoy/3Y/wAj/jR/aEufux/kf8aANOisv+0Jf7qfkf8AGl/tCX+7H+R/xoA08UyQcVnf2hL/AHU/I/40hv5T/Cn5H/GgCWYc16B8K+Im/wCuhrzVrh26ha2NA8UXuhri0jt2G7d+8Unn8CKAPrrwmp8kV2EC/KK+SNO+NviSwUCGz0g4/vQyH/2etJf2hfFq9LHRP+/Ev/xygD6tCYHSoHGDXy5/w0T4u/58dD/78S//ABymN+0J4sY5Njof/fiX/wCOUAfULL+td/oVsLPTo4cfPje/1NfEEX7QviyORH/s/Qm2ndhoJcH/AMiVrJ+1J44V2caf4ey3XNvN/wDHaAPrbU2AmYEGoYUBs7kjj5Cfoa+Rbj9pbxncMWew0AEnPy28o/8AatIv7SvjJY3QafoGHGD/AKPL/wDHaAPrPxGCvhuwj45bJP4GvKPGCjyG49q8h1D9pHxjf20ME1hoKpF93Zbyg9Mf89a57UfjN4iv1KzWmlAH+7FIP/Z6AOP8VD/iqNR/66mq0FV7++lvr+e7mVBLK25go4z7Uxbp16BfyoA1h0pazPt8v91PyP8AjR9vl/up+R/xoA06KzP7Ql/up+R/xo+3y/3U/I/40AR3/wDx9P8Ah/Kksf8Aj6j/AB/lTJpDLIXYAE+lJFIYpA64yPWgDcorM/tCX+6n5H/Gj+0Jf7qfkf8AGgDTorM+3y/3U/I/40f2hL/dT8j/AI0AaTdDVeTvVU38v91PyP8AjTGu5G6hfyoA1tATfqq/7Kk17J4Tg4UmvC7DU5rKYyxJEzEY+YEj+ddPYfEjV7EDybawOP70b/8AxVAH0fZx4QVoIuB0r52j+M3iKMYW00rj1ik/+LqX/hdniT/nz0n/AL8yf/F0AfR+m2/n3qAjKr8xrqr4CNFB9MY9zXyfZfHjxRZszRWWjEnu0Mh/9qVYm/aE8WTD57HRPwgl/wDjlAH1Po+E1G3boGbbW3Ipe8ZVOVVuua+PIv2gvFkUkTrY6JmPp+4l/wDjlXP+GkvGPnNL/Z+g7m6/6PL/APHaAPqa/cG7TJzh81yGtJs1G4UdA5r5+k/aF8WyOrNY6JkHPEEv/wAcqlefHPxPdzvNLZ6OGc5O2GTH/oygD2XWz+4avGvFzYinP+yazbv4t6/dIVktdMAP92J//i65rUvFN9qCOs8duAwwdqkf1oAzIug4q3GOKzVmZegWpBeSDoqfrQBpYoxWf9vl/up+R/xpft8v91PyP+NADtSGPL/H+lUamnnafbvCjHpUNABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cortical bone compression of the distal radius and ulna are evident in both radiographic views (white arrows) and appear as a bony discontinuity or bump.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paula Schweich, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27520=[""].join("\n");
var outline_f26_56_27520=null;
var title_f26_56_27521="Patient information: Huntington disease (The Basics)";
var content_f26_56_27521=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?31/14/31970\">",
"         Patient information: Dementia (including Alzheimer disease) (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Huntington disease (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/huntington-disease-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H25724175\">",
"      <span class=\"h1\">",
"       What is Huntington disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Huntington disease is a disorder that causes people to move in odds ways and that can affect their mood and the way they think. In people with Huntington disease, nerve cells in a part of the brain die. The disease is passed on in families. If your mother or father has Huntington disease, you have a 50-50 chance of having it, too.",
"     </p>",
"     <p>",
"      People with Huntington disease usually start to show symptoms between the ages of 40 and 60. Some people show symptoms much earlier.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25724182\">",
"      <span class=\"h1\">",
"       What are the symptoms of Huntington disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Movements that you can&rsquo;t control in the face, trunk, arms, or legs",
"       </li>",
"       <li>",
"        Feeling depressed, anxious, irritable, angry, or like you don&rsquo;t care about anything",
"       </li>",
"       <li>",
"        Trouble interacting with other people",
"       </li>",
"       <li>",
"        Seeing or believing in things that are not there (called hallucinations)",
"       </li>",
"       <li>",
"        Trouble thinking clearly and forgetting things",
"       </li>",
"       <li>",
"        Weight loss",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      At first, the symptoms may be very slight, but they slowly get worse over time.",
"     </p>",
"     <p>",
"      People with Huntington disease are at risk of suicide. If you feel sad or depressed, talk to your doctor or nurse about it. There are often treatments that can help.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25724189\">",
"      <span class=\"h1\">",
"       Is there a test for Huntington disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. There is a blood test to check for the gene that causes Huntington disease. Some people have this test before they show any symptoms. But if you are thinking of having this test, ask your doctor to send you to a genetic counselor before you have the test. A genetic counselor can help you learn about all the possible risks and benefits of having the test. For instance, a genetic counselor can help you find out:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        What the chances are that your kids will have Huntington disease",
"       </li>",
"       <li>",
"        How soon you might have symptoms, if the test shows you have the disease",
"       </li>",
"       <li>",
"        Whether you could have problems with insurance if the test shows you have the disease",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25724196\">",
"      <span class=\"h1\">",
"       How is Huntington disease treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There is a medicine that helps with the movement problems caused by Huntington disease. It is called",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?13/15/13557?source=see_link\">",
"       tetrabenazine",
"      </a>",
"      (sold as Xenazine&reg;). If it doesn&rsquo;t work, there are other medicines that can help with movement.",
"     </p>",
"     <p>",
"      There are no medicines that deal with all the symptoms of Huntington disease. But there are lots of treatments to help with specific symptoms. For instance, people who are depressed or anxious can take depression and anxiety medicines. Likewise, people who see things that are not real can take medicines to deal with that problem.",
"     </p>",
"     <p>",
"      People with Huntington disease sometimes also use walkers, wheelchairs, or other devices that can help them manage their problems. Plus, they sometimes work with physical or speech therapists to learn special exercises that can help them manage.",
"     </p>",
"     <p>",
"      Unfortunately, there is no cure for Huntington disease. Most people die 10 to 30 years after the symptoms begin. If you have the disease, talk to your loved ones about the type of care you would like to have when you get really sick. That way they will know what to do, even if you become unable to speak for yourself.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25724203\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Talk to your doctor nurse before you start trying to get pregnant. If you are taking medicines, you might need to switch to different medicines that are safer for a baby. You also might want to talk to a genetic counselor about the chances that any children you might have would develop Huntington disease.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25724285\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/14/31970?source=see_link\">",
"       Patient information: Dementia (including Alzheimer disease) (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?26/56/27521?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15820 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-424AE69C25-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27521=[""].join("\n");
var outline_f26_56_27521=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25724175\">",
"      What is Huntington disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25724182\">",
"      What are the symptoms of Huntington disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25724189\">",
"      Is there a test for Huntington disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25724196\">",
"      How is Huntington disease treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25724203\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25724285\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/14/31970?source=related_link\">",
"      Patient information: Dementia (including Alzheimer disease) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_56_27522="Fixed drug eruption patch testing";
var content_f26_56_27522=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Patch testing at the site of a fixed drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 338px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Positive patch test reaction for the causative drug 10% in petrolatum. Note the positive reaction confined to the previously involved pigmented area.",
"    <div class=\"footnotes\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol 2009; 9:316. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27522=[""].join("\n");
var outline_f26_56_27522=null;
var title_f26_56_27523="Childhood immunization schedule 7 to 18 yrs";
var content_f26_56_27523=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 616px\">",
"   <div class=\"ttl\">",
"    Recommended immunization schedule for persons aged 7 through 18 years - United States, 2013 (for those who fall behind or start late, see the schedule below and the catch-up schedule)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 596px; height: 758px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This schedule includes recommendations in effect as of January 1, 2013. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. Vaccination providers should consult the relevant Advisory Committee on Immunization Practices (ACIP) statement for detailed recommendations, available online at",
"    <a href=\"file://www.cdc.gov/vaccines/pubs/acip-list.htm\" target=\"_blank\">",
"     www.cdc.gov/vaccines/pubs/acip-list.htm",
"    </a>",
"    . Clinically significant adverse events that follow vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS) at",
"    <a href=\"file://www.vaers.hhs.gov\" target=\"_blank\">",
"     www.vaers.hhs.gov",
"    </a>",
"    or by telephone, 800-822-7967. Suspected cases of vaccine-preventable diseases should be reported to the state or local health department. Additional information including precautions and contraindications for vaccination is available from the CDC online at",
"    <a href=\"file://www.cdc.gov/vaccines\" target=\"_blank\">",
"     www.cdc.gov/vaccines",
"    </a>",
"    or by telephone, 800-232-4636. This schedule is approved by the ACIP, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.",
"    <div class=\"footnotes\">",
"     *",
"     <strong>",
"      Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine:",
"     </strong>",
"     <em>",
"      (Minimum age: 10 years for Boostrix and 11 years for Adacel)",
"     </em>",
"     Administer 1 dose of Tdap vaccine to all adolescents aged 11 through 12 years. Tdap can be administered regardless of the interval since the last tetanus and diphtheria toxoid-containing vaccine. Administer 1dose of Tdap vaccine to pregnant adolescents during each pregnancy (preferred during 27 through 36 weeks gestation) regardless of number of years from prior Td or Tdap vaccination.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     <strong>",
"      Human papillomavirus (HPV) vaccines (HPV4 [Gardasil] and HPV2 [Cervarix]):",
"     </strong>",
"     <em>",
"      (Minimum age: 9 years)",
"     </em>",
"     Administer a 3-dose series of HPV vaccine on a schedule of 0, 1 to 2, and 6 months to all adolescents aged 11 to 12 years. Either HPV4 or HPV2 may be used for females, and only HPV4 may be used for males. The vaccine series can be started beginning at age 9 years. Administer the second dose 1 to 2 months after the first dose and the third dose 6 months after the first dose (at least 24 weeks after the first dose).",
"     <br/>",
"     &Delta;",
"     <strong>",
"      Meningococcal conjugate vaccines (MCV):",
"     </strong>",
"     <em>",
"      (Minimum age: 9 months for Menactra [MCV4-D], 2 years for Menveo [MCV4-CRM])",
"     </em>",
"     Administer MCV4 vaccine at age 11 to 12 years, with a booster dose at age 16 years. Adolescents aged 11 through 18 years with human immunodeficiency virus (HIV) infection should receive a 2-dose primary series of MCV4, with at least 8 weeks between doses. See MMWR 2011; 60:1018, available at:",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6030.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/wk/mm6030.pdf",
"     </a>",
"     .",
"     <br/>",
"     <strong>",
"      Vaccination of persons with high-risk conditions:",
"     </strong>",
"     For children aged 24 months and older with persistent complement component deficiency or anatomic or functional asplenia (including sickle cell disease), who have not received a complete series of HibMenCY or MCV4-D, administer 2 primary doses of either MCV4-D or MCV4-CRM. MCV4-D should not be administered to a child with asplenia (including sickle cell disease) until at least 4 weeks after the completion of all PCV13 doses. See MMWR 2011; 60:1391, available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6040.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/wk/mm6040.pdf",
"     </a>",
"     . For children aged 9 months and older who are residents of or travelers to countries in the African meningitis belt or to the Hajj, administer an age-appropriate formulation and series of MCV4 for protection against serogroups A and W-135. Prior receipt of HibMenCY is not sufficient for children traveling to the meningitis belt or the Hajj. See MMWR 2011; 60:1391, available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6040.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/wk/mm6040.pdf",
"     </a>",
"     . For children who are present during outbreaks caused by a vaccine serogroup, administer or complete an age- and formulation-appropriate series of MCV4. For booster doses among persons with high-risk conditions refer to",
"     <a href=\"file://www.cdc.gov/vaccines/pubs/acip-list.htm#mening\" target=\"_blank\">",
"      www.cdc.gov/vaccines/pubs/acip-list.htm#mening",
"     </a>",
"     .",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     <strong>",
"      Influenza vaccines:",
"     </strong>",
"     <em>",
"      (Minimum age: 6 months for inactivated influenza vaccine [IIV], 2 years for live, attenuated influenza vaccine [LAIV])",
"     </em>",
"     Administer influenza vaccine annually to all children beginning at age 6 months. For most healthy, nonpregnant persons aged 2 through 49 years, either LAIV or IIV may be used. However, LAIV should NOT be administered to some persons, including 1) those with asthma, 2) children 2 through 4 years who had wheezing in the past 12 months, or 3) those who have any other underlying medical conditions that predispose them to influenza complications. For all other contraindications to use of LAIV see MMWR 2010; 59 (No. RR-8), available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/rr/rr5908.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/rr/rr5908.pdf",
"     </a>",
"     . Administer 1 dose to persons aged 9 years and older. For children aged 6 months through 8 years: 1) For the 2012-13 season, administer 2 doses (separated by at least 4 weeks) to children who are receiving influenza vaccine for the first time. For additional guidance, follow dosing guidelines in the 2012 ACIP influenza vaccine recommendations, MMWR 2012; 61: 613, available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/wk/mm6132.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/wk/mm6132.pdf",
"     </a>",
"     ; 2) For the 2013-14 season, follow dosing guidelines in the 2013 ACIP influenza vaccine recommendations.",
"     <br/>",
"     &sect;",
"     <strong>",
"      Pneumococcal conjugate vaccine (PCV):",
"     </strong>",
"     <em>",
"      (Minimum age: 6 weeks)",
"      <br/>",
"     </em>",
"     <strong>",
"      Vaccination of persons with high-risk conditions:",
"     </strong>",
"     A single dose of PCV13 may be administered to previously unvaccinated children aged 6 through 18 years who have anatomic or functional asplenia (including sickle cell disease), HIV infection or an immunocompromising condition, cochlear implant or cerebrospinal fluid leak. See MMWR 2010; 59 (No. RR-11), available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/rr/rr5911.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/rr/rr5911.pdf",
"     </a>",
"     . Administer PPSV23 at least 8 weeks after the last dose of PCV to children aged 2 years or older with high risk conditions (listed below).",
"     <br/>",
"     <strong>",
"      High risk conditions for pneumococcal vaccine:",
"     </strong>",
"     1) Immunocompetent children with chronic heart disease (particularly cyanotic congenital heart disease and cardiac failure); chronic lung disease (including asthma if treated with high-dose oral corticosteroid therapy), diabetes mellitus; cerebrospinal fluid leaks; or cochlear implant. 2) Children with anatomic or functional asplenia (including sickle cell disease and other hemoglobinopathies, congenital or acquired asplenia, or splenic dysfunction). 3) Children with immunocompromising conditions: HIV infection, chronic renal failure and nephrotic syndrome, diseases associated with treatment with immunosuppressive drugs or radiation therapy, including malignant neoplasms, leukemias, lymphomas and Hodgkin disease; or solid organ transplantation, congenital immunodeficiency.",
"     <br/>",
"     &yen;",
"     <strong>",
"      Pneumococcal polysaccharide vaccine (PPSV23):",
"     </strong>",
"     <em>",
"      (Minimum age: 2 years)",
"     </em>",
"     Administer PPSV23 at least 8 weeks after the last dose of PCV to children aged 2 years or older with high-risk conditions (listed above). A single revaccination with PPSV23 should be administered after 5 years to children with anatomic or functional asplenia (including sickle cell disease) or an immunocompromising condition.",
"     <br/>",
"     &Dagger;",
"     <strong>",
"      Hepatitis A (HepA) vaccine:",
"     </strong>",
"     For any person aged 2 years and older who has not already received the HepA vaccine series, 2 doses of HepA vaccine separated by 6 to 18 months may be administered if immunity against hepatitis A virus infection is desired.",
"     <br/>",
"     <strong>",
"      Special populations:",
"     </strong>",
"     Administer 2 doses of HepA vaccine at least 6 months apart to previously unvaccinated persons who live in areas where vaccination programs target older children, or who are at increased risk for infection.",
"     <br/>",
"     &dagger;",
"     <strong>",
"      Hepatitis B (HepB) vaccine:",
"     </strong>",
"     Unvaccinated persons should complete a 3-dose series. A 2-dose series (doses separated by at least 4 months) of adult formulation Recombivax HB is licensed for use in children aged 11 through 15 years.",
"     <br/>",
"     **",
"     <strong>",
"      Inactivated poliovirus (IPV) vaccine:",
"     </strong>",
"     A fourth dose is not necessary if the third dose was administered at age 4 years or older and at least 6 months after the previous dose. If both oral polio vaccine (OPV) and IPV were administered as part of a series, a total of 4 doses should be administered, regardless of the child's current age. IPV is not routinely recommended for US residents aged 18 years or older.",
"     <br/>",
"     <span class=\"double_bullet\">",
"      &bull;&bull;",
"     </span>",
"     <strong>",
"      Measles, mumps, and rubella (MMR) vaccine:",
"     </strong>",
"     Ensure that all school-aged children and adolescents have had 2 doses of MMR vaccine; the minimum interval between the 2 doses is 4 weeks.",
"     <br/>",
"     &Delta;&Delta;",
"     <strong>",
"      Varicella (VAR) vaccine:",
"     </strong>",
"     Ensure that all persons aged 7 through 18 years without evidence of immunity (see MMWR 2007; 56 [No. RR-4], available at",
"     <a href=\"file://www.cdc.gov/mmwr/pdf/rr/rr5604.pdf\" target=\"_blank\">",
"      www.cdc.gov/mmwr/pdf/rr/rr5604.pdf",
"     </a>",
"     ) have 2 doses of varicella vaccine. For children aged 7 through 12 years the recommended minimum interval between doses is 3 months (if the second dose was administered at least 4 weeks after the first dose, it can be accepted as valid); for persons aged 13 years and older, the minimum interval between doses is 4 weeks.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Akinsanya-Beysolow I, Jenkins R, Meissner HC, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC. Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedule for Persons Aged 0 Through 18 Years - United States, 2013. MMWR Surveill Summ 2013; 62:2. Available at:&nbsp;",
"     <a href=\"file://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-schedule.pdf\" target=\"_blank\">",
"      www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-schedule.pdf",
"     </a>",
"     (Accessed on February 3, 2013).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27523=[""].join("\n");
var outline_f26_56_27523=null;
var title_f26_56_27524="Shoulder anat posterior PI";
var content_f26_56_27524=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F63139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F63139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 564px\">",
"   <div class=\"ttl\">",
"    Posterior view of shoulder anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 544px; height: 456px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27524=[""].join("\n");
var outline_f26_56_27524=null;
var title_f26_56_27525="Anatomy of the head and neck";
var content_f26_56_27525=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F75396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F75396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Anatomy of the head and neck",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 477px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Representation of the different regions of the head and neck at which cancer can develop. The oral cavity includes the lip, floor of the mouth, oral tongue, alveolar ridge, retromolar trigone, hard palate, and buccal mucosa. The oropharynx includes the soft palate, tonsil, posterior and lateral pharyngeal walls, and base of the tongue. The hypopharynx includes the pyriform fossa, lateral and posterior hypopharyngeal walls, and postericoid region. The larynx includes the supraglottic, glottic, and subglottic larynx.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Used with permission of the American Joint Committee on Cancer (AJCC&reg;), Chicago, Illinois. The original source for this material is the AJCC&reg; Cancer Staging Manual, 5th edition (1997) published by Lippincott-Raven Publishers, Philadelphia, Pennsylvania.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27525=[""].join("\n");
var outline_f26_56_27525=null;
var title_f26_56_27526="Pemphigus vulgaris bullae and erosions";
var content_f26_56_27526=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flaccid bullae and erosions on the skin of a patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27526=[""].join("\n");
var outline_f26_56_27526=null;
var title_f26_56_27527="Predictive scoring systems in the intensive care unit";
var content_f26_56_27527=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Predictive scoring systems in the intensive care unit",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/56/27527/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/56/27527/contributors\">",
"     Mark A Kelley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/56/27527/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/56/27527/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/56/27527/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/56/27527/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/56/27527/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Predictive scoring systems have been developed to measure the severity of disease and the prognosis of patients in the intensive care unit (ICU). Such measurements are helpful for clinical decision making, standardizing research, and comparing the quality of patient care across ICUs.",
"   </p>",
"   <p>",
"    Four validated predictive scoring systems are described here. They include the Acute Physiologic and Chronic Health Evaluation (APACHE) system, Simplified Acute Physiologic Score (SAPS), Mortality Prediction Model (MPM), and Sequential Organ Failure Assessment score (SOFA).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HOW PREDICTIVE SCORING SYSTEMS WORK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Critical care predictive scoring systems derive a numerical value, or severity score, from a variety of clinical variables. The severity score quantifies the severity of illness. It can be entered into a mathematical equation whose solution is the likelihood of a clinical outcome, usually mortality.",
"   </p>",
"   <p>",
"    The relationship between the severity score and the outcome is determined empirically from large data sets. Predictive scoring systems cannot predict outcomes for populations that were not included in the derivation data sets. Thus, ICU predictive scoring systems should not be used for patients outside of the critical care setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CHARACTERISTICS OF PREDICTIVE SCORING SYSTEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two principles that are important to consider when assessing a predictive scoring system (ie, outcome instrument). First, an instrument should measure an important outcome. Most ICU scoring systems assess hospital mortality, while others predict long-term mortality and functional status. Second, an instrument should be easy to use, since collecting data on critically ill patients can be time consuming and costly.",
"   </p>",
"   <p>",
"    Discrimination and calibration are two characteristics used to judge a predictive system:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Discrimination describes the accuracy of a given prediction. As an example, if a scoring instrument predicts a mortality of 90 percent, discrimination is perfect if the observed mortality is 90 percent.",
"     </li>",
"     <li>",
"      Calibration describes how the instrument performs over a wide range of predicted mortalities. In the example above, a predictive instrument would be highly calibrated if it were accurate at mortalities of 90, 50, and 20 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREDICTIVE SCORING SYSTEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The four major ICU predictive scoring systems are the Acute Physiologic and Chronic Health Evaluation (APACHE) scoring system, the Simplified Acute Physiologic Score (SAPS), the Mortality Prediction Model (MPM), and the Sequential Organ Failure Assessment (SOFA).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute Physiologic and Chronic Health Evaluation (APACHE)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Acute Physiologic and Chronic Health Evaluation (APACHE) scoring system is widely used in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/1\">",
"     1",
"    </a>",
"    ]. The most recent versions include APACHE II through IV.",
"   </p>",
"   <p>",
"    APACHE requires the input of many clinical variables, from which a severity score is derived. The resulting severity score is entered into a logistical regression equation, which predicts mortality. The required variables differ among the versions, but generally include factors such as age, diagnosis, prior treatment location, and numerous acute physiologic and chronic health variables. APACHE uses the worst values from the initial 24 hours of ICU admission.",
"   </p>",
"   <p>",
"    All of the APACHE instruments have excellent discrimination, but less impressive calibration. Like most predictive models, APACHE requires periodic retesting, revising, and updating because its accuracy decreases as treatments and other factors influencing mortality change.",
"   </p>",
"   <p>",
"    The most frequently cited APACHE models are APACHE II and III, although APACHE IV has also been validated:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      APACHE II &ndash; The variables used to calculate the APACHE II severity score are shown in the calculator (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?3/8/3205?source=see_link\">",
"       calculator 1",
"      </a>",
"      ). Although the APACHE II severity score is supposed to be based upon the worst variables during the initial 24 hours in the ICU, a severity score based upon ICU admission data appears to be an acceptable alternative [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/2\">",
"       2",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The APACHE II scoring system is imperfect. Outcome cannot be accurately predicted for any specific patient subgroup (eg, liver failure, sepsis, etc.) and the predicted mortality is less than the observed mortality among ICU patients who are transferred from other inpatient facilities [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/3,4\">",
"       3,4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      APACHE III &ndash; APACHE III resembles APACHE II, except that several variables have been added (eg, diagnosis, prior treatment location) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/5\">",
"       5",
"      </a>",
"      ]. A unique feature of the APACHE III scoring system is that it uses daily updates of clinical information to recalculate estimated mortality on a daily basis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/5\">",
"       5",
"      </a>",
"      ]. Although this has greater predictive power than a single projection based upon the first 24 hours of ICU admission [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/6\">",
"       6",
"      </a>",
"      ], it appears unlikely to enhance clinical decision making until communication between physicians, patients, and their families improves [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      APACHE IV &ndash; APACHE IV uses a new logistical regression equation, a different set of variables, and new statistical modeling. The value of this version was illustrated by an observational study of 110,588 consecutive ICU admissions that found that APACHE IV predicted mortality more accurately than APACHE III [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/8\">",
"       8",
"      </a>",
"      ]. A similar study found that APACHE IV predicted ICU length of stay [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Simplified Acute Physiologic Score (SAPS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Simplified Acute Physiologic Score (SAPS) streamlines data collection and analysis without compromising diagnostic accuracy. The SAPS II is the most widely used version. It calculates a severity score using the worst values measured during the initial 24 hours in the ICU for 17 variables. The variables are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef53023 \" href=\"UTD.htm?42/22/43373\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Several of the variables (ie, AIDS, metastatic cancer, hematological malignancy) are dichotomous, meaning that they are either present or absent. The others are continuous variables that have been made categorical by assigning points to ranges of values. As an example, a systolic blood pressure &ge;200 mmHg is worth 2 points, 100 to 199 mmHg is worth 0 points, 70 to 99 mmHg is worth 5 points, and &lt;70 mmHg is worth 13 points.",
"   </p>",
"   <p>",
"    Higher severity scores indicate more severe illness. The SAPS II can be entered into a mathematical formula, which predicts hospital mortality.",
"   </p>",
"   <p>",
"    The SAPS II was based upon data from 8500 patients and was validated on a sample of 4500 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/10\">",
"     10",
"    </a>",
"    ]. It has excellent discrimination and calibration [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/11\">",
"     11",
"    </a>",
"    ]. It may also be suitable for use in the intermediate care unit setting [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/12\">",
"     12",
"    </a>",
"    ]. However, the SAPS II may be less accurate among patients who are admitted to the ICU for noncardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An updated version, the SAPS III, was validated using data from patients in more than 100 ICUs in multiple countries [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/14\">",
"     14",
"    </a>",
"    ]. However, a subsequent study of more than 28,000 patients from 147 ICUs in one country found that the SAPS III had good discrimination, but poor calibration [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/15\">",
"     15",
"    </a>",
"    ]. This finding has been replicated in more recent studies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Mortality Prediction Model (MPM)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Mortality Prediction Model II (MPM II) is the most common version of the MPM. A severity score is calculated from 15 variables, as assessed at the time of ICU admission. The variables are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef77798 \" href=\"UTD.htm?12/52/13133\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Except for age, all of the variables are dichotomous. In other words, they are either present or absent. As an example, a systolic blood pressure &le;90 mmHg is worth one point, while all other systolic blood pressure values are assigned zero points. The final score is entered into a mathematical formula whose solution provides the predicted mortality.",
"   </p>",
"   <p>",
"    The MPM II severity score that is measured on admission (MPM II 0) can be refined after 24 hours (MPM II 24) by updating seven of the admission variables and adding six variables. The updated admission variables include coma, intracranial mass effect, mechanical ventilation, metastatic disease, cirrhosis, type of admission, and patient age. The additional variables include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Creatinine &gt;2",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"     </li>",
"     <li>",
"      Urine output &lt;150 mL over eight hours",
"     </li>",
"     <li>",
"      Confirmed infection",
"     </li>",
"     <li>",
"      Vasoactive medications for &ge;1 hour",
"     </li>",
"     <li>",
"      Arterial oxygen tension (PaO",
"      <sub>",
"       2",
"      </sub>",
"      ) &lt;60 mmHg",
"     </li>",
"     <li>",
"      Prothrombin time greater than the sum of the standard plus three seconds",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An advantage of the MPM II 24 is that it can be compared to the SAPS and APACHE, since all three scores are determined after the first 24 hours of admission.",
"   </p>",
"   <p>",
"    The MPM II is based upon data from over 12,500 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/17\">",
"     17",
"    </a>",
"    ]. It has excellent calibration and discrimination [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/11,17,18\">",
"     11,17,18",
"    </a>",
"    ]. An updated version, the MPM0-III, has excellent calibration, as validated on a large cohort of over 55,000 ICU patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Sequential Organ Failure Assessment (SOFA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Sequential Organ Failure Assessment (SOFA) uses simple measurements of major organ function to calculate a severity score. The scores are calculated 24 hours after admission to the ICU and every 48 hours thereafter. The mean and the highest scores are most predictive of mortality. In addition, scores that increase by about 30 percent are associated with a mortality of at least 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The SOFA severity score is based upon the following measurements of organ function:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Respiratory system: the ratio of arterial oxygen tension to fraction of inspired oxygen",
"      <span class=\"nowrap\">",
"       (PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"       )",
"      </span>",
"     </li>",
"     <li>",
"      Cardiovascular system: the amount of vasoactive medication necessary to prevent hypotension",
"     </li>",
"     <li>",
"      Hepatic system: the bilirubin level",
"     </li>",
"     <li>",
"      Coagulation system: the platelet concentration",
"     </li>",
"     <li>",
"      Neurologic system: the Glasgow coma score",
"     </li>",
"     <li>",
"      Renal system: the serum creatinine or urine output",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The original SOFA instrument was derived from a cohort of 1449 patients admitted to 40 ICUs in 16 countries [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     COMPARISON OF THE PREDICTIVE SCORING SYSTEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The four major ICU predictive scoring systems (APACHE, SAPS, MPM, SOFA) and their most recent updates all have acceptable discrimination and calibration [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/18,22\">",
"     18,22",
"    </a>",
"    ]. However, there are important limitations and methodological differences among these instruments, including the collection of data, calculation of mortality, efficacy, and cost [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Data collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The types of variables that are measured and the timing of those measurements vary among the predictive scoring systems:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Variables measured &ndash; The APACHE scoring system requires collection of a wide range of physiological and general health data, while the other instruments use concise and easily measured physiological categories to facilitate data recording [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Timing of the measurements &ndash; The APACHE and SAPS instruments use the worst physiologic values measured within 24 hours of admission to the ICU. The MPM uses data collected upon ICU admission and then modified 24 hours later, while the SOFA instrument uses data collected 24 hours after admission and every 48 hours thereafter.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Calculations",
"    </span>",
"    &nbsp;&mdash;&nbsp;All four predictive instruments (APACHE, SAPS, MPM, and SOFA) provide a severity score to describe each patient. This score is the sum of categorical variables described above. The severity score is the most commonly used application of predictive instruments.",
"   </p>",
"   <p>",
"    Predicted mortality can also be assessed from these severity scores. For APACHE, a predicted mortality is calculated from the computer software described above. For SAPS and MPM, the severity score is entered into an equation that calculates a predicted mortality. For SOFA, sequential severity scores plot the trajectory of the clinical course to provide a semi-quantitative assessment of mortality, based upon multi-organ failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been no large studies that rigorously compare the four major ICU predictive scoring systems (APACHE, SAPS, MPM, SOFA). The following studies illustrate the existing evidence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One retrospective study of 11,300 ICU patients from 35 hospitals compared the MPM III, SAPS II, and APACHE IV instruments [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/25\">",
"       25",
"      </a>",
"      ]. APACHE IV offered the best predictive accuracy. However, MPM III proved to be an effective alternative when cost and the complexity of data collection were considered [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A systemic review of the SOFA, SAPS II, APACHE II, and APACHE III scoring systems found that the APACHE systems were slightly superior to the SAPS II and SOFA systems in predicting ICU mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/22\">",
"       22",
"      </a>",
"      ]. The accuracy of both the SAPS II and APACHE instruments improved when combined with the assessment of sequential SOFA scores.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cost",
"    </span>",
"    &nbsp;&mdash;&nbsp;The APACHE III and IV predictive scoring systems tend to be the most costly because they require proprietary computer technology and substantial data collection. In contrast, APACHE II calculation software is available to the public (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?3/8/3205?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). The MPM, SAPS, and SOFA scoring systems are available to the public, require less data collection, and require no computer investment. Calculations are easily made from published equations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     USES FOR PREDICTIVE SCORING SYSTEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prognosis was the main goal of ICU predictive scoring systems. However, the severity scores in themselves have proven highly useful [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severity scores facilitate evaluation of various interventions by ensuring that patients with similar baseline risk are being compared [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/27\">",
"       27",
"      </a>",
"      ]. This is particularly common among trials of potential therapies for sepsis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/28,29\">",
"       28,29",
"      </a>",
"      ] or acute respiratory distress syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/30,31\">",
"       30,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Severity scores facilitate evaluation of the quality of care by ensuring that patients with similar baseline risk are being compared. As examples, studies that compared open with closed ICUs [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/32-37\">",
"       32-37",
"      </a>",
"      ], the outcomes of different ICUs within a hospital [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/38\">",
"       38",
"      </a>",
"      ], and the outcomes of ICUs in different hospitals [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/38-40\">",
"       38-40",
"      </a>",
"      ] have used predictive scoring systems (usually APACHE) to ensure that patients with similar baseline risk were compared.",
"     </li>",
"     <li>",
"      Severity scores have been used to manage hospital resources, assigning patients with lower severity scores to less expensive settings [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     LIMITATIONS OF PREDICTIVE SCORING SYSTEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ICU is the ideal setting for predictive scoring systems because the population is well defined, patient care is well circumscribed, and there is a lot of evidence that the severity of illness in the ICU is the major determinant of hospital mortality. Despite this, predictive scoring systems have important limitations [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Disease subsets &ndash; Predictive scoring systems are developed from large data sets of ICU patients. However, these data sets are too small to assess diseases separately. As a result, the predicted mortality of patients with certain diseases (eg, liver failure, obstetrical diseases, AIDS) may be inaccurate [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/44-46\">",
"       44-46",
"      </a>",
"      ]. This may also apply to specialized ICUs in which some investigators have used their own validation subsets to adjust for this flaw [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lead time bias &ndash; Patients who are transferred from other hospitals and ICUs have a mortality that is higher than predicted by the APACHE II system, a phenomenon known as lead time bias [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/3\">",
"       3",
"      </a>",
"      ]. To address this flaw, treatment location was added as a variable to APACHE III. It is uncertain whether lead time bias affects the other predictive scoring systems (ie, SAPS, MPM, or SOFA).",
"     </li>",
"     <li>",
"      Need for updates &ndash; All of the predictive scoring systems must be periodically updated using more current data or they may fail to capture the effects of new technology, practice patterns, or standards of care. The impact of not updating predictive scoring systems is a gradual loss of calibration over time. This results in overestimating mortality for any given severity score [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27527/abstract/16\">",
"       16",
"      </a>",
"      ]. Studies have found that this is a common flaw among all predictive scoring systems.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Predictive scoring systems derive a severity score from a variety of clinical variables. This score quantifies the severity of illness and can be entered into a mathematical equation whose solution is the likelihood of a clinical outcome, usually mortality. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'How predictive scoring systems work'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The four major intensive care unit (ICU) predictive scoring systems are the Acute Physiologic and Chronic Health Evaluation (APACHE) scoring system, Simplified Acute Physiologic Score (SAPS), Mortality Prediction Model (MPM), and Sequential Organ Failure Assessment (SOFA). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Acute Physiologic and Chronic Health Evaluation (APACHE)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Simplified Acute Physiologic Score (SAPS)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Mortality Prediction Model (MPM)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Sequential Organ Failure Assessment (SOFA)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Comparison of the predictive scoring systems'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although prognosis is the main goal of the ICU predictive scoring systems, the severity scores may also be used to manage hospital resources or to ensure that patients with similar baseline risk are being compared in studies evaluating interventions or quality of care. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Uses for predictive scoring systems'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The ICU predictive scoring systems require periodic updating, may be inaccurate in patients with certain disease (eg, liver failure, obstetrical diseases, AIDS), and may be limited by lead time bias. Poor calibration among these scoring systems results in overestimation of predicted mortality. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Limitations of predictive scoring systems'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/1\">",
"      Cowen JS, Kelley MA. Errors and bias in using predictive scoring systems. Crit Care Clin 1994; 10:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/2\">",
"      Ho KM, Dobb GJ, Knuiman M, et al. A comparison of admission and worst 24-hour Acute Physiology and Chronic Health Evaluation II scores in predicting hospital mortality: a retrospective cohort study. Crit Care 2006; 10:R4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/3\">",
"      Escarce JJ, Kelley MA. Admission source to the medical intensive care unit predicts hospital death independent of APACHE II score. JAMA 1990; 264:2389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/4\">",
"      Capuzzo M, Valpondi V, Sgarbi A, et al. Validation of severity scoring systems SAPS II and APACHE II in a single-center population. Intensive Care Med 2000; 26:1779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/5\">",
"      Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/6\">",
"      Wagner DP, Knaus WA, Harrell FE, et al. Daily prognostic estimates for critically ill adults in intensive care units: results from a prospective, multicenter, inception cohort analysis. Crit Care Med 1994; 22:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/7\">",
"      A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995; 274:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/8\">",
"      Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med 2006; 34:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/9\">",
"      Zimmerman JE, Kramer AA, McNair DS, et al. Intensive care unit length of stay: Benchmarking based on Acute Physiology and Chronic Health Evaluation (APACHE) IV. Crit Care Med 2006; 34:2517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/10\">",
"      Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/11\">",
"      Castella X, Artigas A, Bion J, Kari A. A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American Severity Study Group. Crit Care Med 1995; 23:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/12\">",
"      Auriant I, Vinatier I, Thaler F, et al. Simplified acute physiology score II for measuring severity of illness in intermediate care units. Crit Care Med 1998; 26:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/13\">",
"      Metnitz PG, Valentin A, Vesely H, et al. Prognostic performance and customization of the SAPS II: results of a multicenter Austrian study. Simplified Acute Physiology Score. Intensive Care Med 1999; 25:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/14\">",
"      Ledoux D, Canivet JL, Preiser JC, et al. SAPS 3 admission score: an external validation in a general intensive care population. Intensive Care Med 2008; 34:1873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/15\">",
"      Poole D, Rossi C, Anghileri A, et al. External validation of the Simplified Acute Physiology Score (SAPS) 3 in a cohort of 28,357 patients from 147 Italian intensive care units. Intensive Care Med 2009; 35:1916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/16\">",
"      Nassar AP Jr, Mocelin AO, Nunes AL, et al. Caution when using prognostic models: a prospective comparison of 3 recent prognostic models. J Crit Care 2012; 27:423.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/17\">",
"      Lemeshow S, Teres D, Klar J, et al. Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. JAMA 1993; 270:2478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/18\">",
"      Lemeshow S, Le Gall JR. Modeling the severity of illness of ICU patients. A systems update. JAMA 1994; 272:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/19\">",
"      Higgins TL, Kramer AA, Nathanson BH, et al. Prospective validation of the intensive care unit admission Mortality Probability Model (MPM0-III). Crit Care Med 2009; 37:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/20\">",
"      Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/21\">",
"      Vincent JL, de Mendon&ccedil;a A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on \"sepsis-related problems\" of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26:1793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/22\">",
"      Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care 2008; 12:R161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/23\">",
"      Glance LG, Osler TM, Dick A. Rating the quality of intensive care units: is it a function of the intensive care unit scoring system? Crit Care Med 2002; 30:1976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/24\">",
"      Glance LG, Osler TM, Dick AW. Identifying quality outliers in a large, multiple-institution database by using customized versions of the Simplified Acute Physiology Score II and the Mortality Probability Model II0. Crit Care Med 2002; 30:1995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/25\">",
"      Kuzniewicz MW, Vasilevskis EE, Lane R, et al. Variation in ICU risk-adjusted mortality: impact of methods of assessment and potential confounders. Chest 2008; 133:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/26\">",
"      Kollef MH, Schuster DP. Predicting intensive care unit outcome with scoring systems. Underlying concepts and principles. Crit Care Clin 1994; 10:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/27\">",
"      Knaus WA, Wagner DP, Zimmerman JE, Draper EA. Variations in mortality and length of stay in intensive care units. Ann Intern Med 1993; 118:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/28\">",
"      Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/29\">",
"      Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/30\">",
"      Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/31\">",
"      Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996; 334:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/32\">",
"      Pronovost PJ, Angus DC, Dorman T, et al. Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA 2002; 288:2151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/33\">",
"      Multz AS, Chalfin DB, Samson IM, et al. A \"closed\" medical intensive care unit (MICU) improves resource utilization when compared with an \"open\" MICU. Am J Respir Crit Care Med 1998; 157:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/34\">",
"      Dimick JB, Pronovost PJ, Heitmiller RF, Lipsett PA. Intensive care unit physician staffing is associated with decreased length of stay, hospital cost, and complications after esophageal resection. Crit Care Med 2001; 29:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/35\">",
"      Li TC, Phillips MC, Shaw L, et al. On-site physician staffing in a community hospital intensive care unit. Impact on test and procedure use and on patient outcome. JAMA 1984; 252:2023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/36\">",
"      Brown JJ, Sullivan G. Effect on ICU mortality of a full-time critical care specialist. Chest 1989; 96:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/37\">",
"      Carson SS, Stocking C, Podsadecki T, et al. Effects of organizational change in the medical intensive care unit of a teaching hospital: a comparison of 'open' and 'closed' formats. JAMA 1996; 276:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/38\">",
"      Afessa B, Keegan MT, Hubmayr RD, et al. Evaluating the performance of an institution using an intensive care unit benchmark. Mayo Clin Proc 2005; 80:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/39\">",
"      Zimmerman JE, Alzola C, Von Rueden KT. The use of benchmarking to identify top performing critical care units: a preliminary assessment of their policies and practices. J Crit Care 2003; 18:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/40\">",
"      Zimmerman JE, Shortell SM, Knaus WA, et al. Value and cost of teaching hospitals: a prospective, multicenter, inception cohort study. Crit Care Med 1993; 21:1432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/41\">",
"      Zimmerman JE, Wagner DP, Knaus WA, et al. The use of risk predictions to identify candidates for intermediate care units. Implications for intensive care utilization and cost. Chest 1995; 108:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/42\">",
"      Katsaragakis S, Papadimitropoulos K, Antonakis P, et al. Comparison of Acute Physiology and Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiology Score II (SAPS II) scoring systems in a single Greek intensive care unit. Crit Care Med 2000; 28:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/43\">",
"      Patel PA, Grant BJ. Application of mortality prediction systems to individual intensive care units. Intensive Care Med 1999; 25:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/44\">",
"      Barie PS, Hydo LJ, Fischer E. Comparison of APACHE II and III scoring systems for mortality prediction in critical surgical illness. Arch Surg 1995; 130:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/45\">",
"      Brown MC, Crede WB. Predictive ability of acute physiology and chronic health evaluation II scoring applied to human immunodeficiency virus-positive patients. Crit Care Med 1995; 23:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/46\">",
"      Lewinsohn G, Herman A, Leonov Y, Klinowski E. Critically ill obstetrical patients: outcome and predictability. Crit Care Med 1994; 22:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27527/abstract/47\">",
"      Sakr Y, Krauss C, Amaral AC, et al. Comparison of the performance of SAPS II, SAPS 3, APACHE II, and their customized prognostic models in a surgical intensive care unit. Br J Anaesth 2008; 101:798.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1655 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-AEB5EC0217-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27527=[""].join("\n");
var outline_f26_56_27527=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HOW PREDICTIVE SCORING SYSTEMS WORK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CHARACTERISTICS OF PREDICTIVE SCORING SYSTEMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREDICTIVE SCORING SYSTEMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute Physiologic and Chronic Health Evaluation (APACHE)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Simplified Acute Physiologic Score (SAPS)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Mortality Prediction Model (MPM)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Sequential Organ Failure Assessment (SOFA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      COMPARISON OF THE PREDICTIVE SCORING SYSTEMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Data collection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Calculations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cost",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      USES FOR PREDICTIVE SCORING SYSTEMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      LIMITATIONS OF PREDICTIVE SCORING SYSTEMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1655\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1655|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/22/43373\" title=\"table 1\">",
"      SAPS II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/52/13133\" title=\"table 2\">",
"      MPM II",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?3/8/3205?source=related_link\" title=\"calculator 1\">",
"      Calculator: APACHE II scoring system",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_56_27528="Chest Xray of pneumothorax after stab wound";
var content_f26_56_27528=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56589%7EPULM%2F70484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56589%7EPULM%2F70484&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chest radiograph of a pneumothorax after stab wound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 321px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This plain chest radiograph shows a left apicolateral pneumothorax with typical convex white visceral pleural line (yellow arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT scan of posttraumatic bilateral pneumothoraces",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows large right and small left anterior pneumothoraces, bibasilar pulmonary contusions, and bilateral subcutaneous emphysema.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27528=[""].join("\n");
var outline_f26_56_27528=null;
var title_f26_56_27529="Neonatal HSV scalp vesicles";
var content_f26_56_27529=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56041%7EPEDS%2F75059%7EPEDS%2F78598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56041%7EPEDS%2F75059%7EPEDS%2F78598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Neonatal herpes simplex virus scalp vesicles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scalp lesions of neonate with skin, eye, and mouth neonatal herpes simplex virus (HSV)&nbsp;infection associated with fetal scalp monitor. Gram-stained smear and bacterial cultures were negative, and the lesions did not respond to topical and systemic antibiotics. Viral cultures grew HSV type 2, and the lesions responded to intravenous acyclovir.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jane Troendle-Atkins, MD, and Gail J Demmler-Harrison, MD, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Neck vesicles in neonate with herpes simplex virus infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The early, untreated skin lesions associated with neonatal herpes simplex virus (HSV) infection are characteristically clear vesicles on an erythematous base, often touching or \"kissing,\" or coalesced in groups of vesicles. Culture of the clear fluid aspirated or swabbed from the vesicles will readily grow HSV in 24 to 48 hours, and slides made from cells scraped from the base of the lesion will show HSV viral antigens by direct immunofluorescence assay (DFA).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gail J Demmler-Harrison, MD, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eye vesicles in neonate with herpes simplex virus infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 230px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Neonate with herpes simplex virus (HSV) infection of the eye, showing characteristic coalescing vesicles on an erythematous base on eyelid and surrounding skin. Ophthalmologic evaluation of the eye should also be performed to determine if keratitis or keratoconjunctivitis is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jenny Ravenscroft, MD, and Gail J Demmler-Harrison, MD, Department of Pediatrics, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27529=[""].join("\n");
var outline_f26_56_27529=null;
var title_f26_56_27530="Lymphocytic and collagenous colitis (microscopic colitis)";
var content_f26_56_27530=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lymphocytic and collagenous colitis (microscopic colitis)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/56/27530/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/56/27530/contributors\">",
"     Christoph F Dietrich, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/56/27530/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/56/27530/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/56/27530/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/56/27530/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/56/27530/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microscopic colitis is characterized by chronic watery (secretory) diarrhea without bleeding, often associated with fecal urgency, and typically occurs in middle-aged patients, but it can affect children. The colon appears normal by colonoscopy or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema. The diagnosis is established by biopsy of the colonic mucosa, which reveals colitis, but without any mucosal ulcerations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two different types of microscopic colitis have been generally recognized [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lymphocytic colitis",
"     </li>",
"     <li>",
"      Collagenous colitis without lymphocytic infiltration of the surface epithelium",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A mixed form, characterized by both thickening of the collagen plate and an increased number of intraepithelial lymphocytes has also been described. However, thickening of the collagen band without evidence of colitis may be seen in a variety of conditions such as in the mucosa adjacent to an adenoma, in ischemic colitis, and chronic trauma.",
"   </p>",
"   <p>",
"    Collagenous colitis was first described in 1976 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/2\">",
"     2",
"    </a>",
"    ]; since that time, multiple cases have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/1,3-9\">",
"     1,3-9",
"    </a>",
"    ]. It is characterized by a thickened subepithelial collagenous band in the colonic mucosa that varies in thickness from 7 to as much as 100 &micro;m (normal is 1 to 7 &micro;m, with a more prominent band in the rectum) (",
"    <a class=\"graphic graphic_picture graphicRef60570 graphicRef74390 \" href=\"UTD.htm?40/2/41002\">",
"     picture 1A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/5,9,10\">",
"     5,9,10",
"    </a>",
"    ]. In comparison, lymphocytic colitis is characterized by a subepithelial lymphocytic infiltrate without excess collagen in the colonic mucosa (",
"    <a class=\"graphic graphic_picture graphicRef54897 \" href=\"UTD.htm?39/3/39993\">",
"     picture 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/1,8,11,12\">",
"     1,8,11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been suggested that these disorders may be caused by a single pathogenetic mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/13\">",
"     13",
"    </a>",
"    ]. Furthermore, because of the similar clinical manifestations of the different types of microscopic colitis, the term \"watery diarrhea-colitis syndrome\" has been suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/14\">",
"     14",
"    </a>",
"    ]. However, it is not known if these disorders are related (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Pathogenesis'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/10,15\">",
"     10,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other variants of microscopic colitis have been described, such as pericrypt eosinophilic enterocolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/16\">",
"     16",
"    </a>",
"    ] and colitis associated with increased mast cells in the colonic mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/17\">",
"     17",
"    </a>",
"    ]. The relationship between these disorders and those described above is uncertain. Pericrypt eosinophilic enterocolitis is often associated with a systemic connective tissue disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/16\">",
"     16",
"    </a>",
"    ]. Collagenous gastritis has histologic features resembling collagenous enterocolitis but is very rare [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lymphocytic and collagenous colitis affect primarily the colon but can also involve the terminal ileum. This was illustrated in a study that included 22 patients with lymphocytic colitis and 23 with collagenous colitis in whom biopsies of the terminal ileum were available [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/19\">",
"     19",
"    </a>",
"    ]. The biopsies were evaluated for the number of intraepithelial lymphocytes (IEL) per 100 epithelial cells (EC) in the villi and crypts. Results were compared with those of 30 patients with inflammatory bowel disease and 24 healthy controls. The presence of &gt;5",
"    <span class=\"nowrap\">",
"     IELs/100",
"    </span>",
"    EC was highly specific for lymphocytic and collagenous colitis (specificity 98 percent with corresponding sensitivity of 73 and 56 percent, respectively). The IEL phenotype was similar in the ileum and colon of individual patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several population-based studies have evaluated the incidence of microscopic colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/5,20-24\">",
"     5,20-24",
"    </a>",
"    ]. Incidence estimates for collagenous colitis have ranged from 1.1 to 5.2 per 100,000 per year and corresponding estimates for lymphocytic colitis have ranged from 3.1 to 5.5 per 100,000 per year.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The largest population-based study in the United States estimated the incidence was 8.6 per 100,000 person-years between 1985 and 2001 [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/23\">",
"       23",
"      </a>",
"      ]. However, there was a significant increase in incidence toward the end of the observation period (incidence almost 20 per 100,000 person years). The incidence increased with age. Collagenous, but not lymphocytic colitis, was more common in women. The overall prevalence was 103 per 100,000 persons.",
"     </li>",
"     <li>",
"      One of the largest population-based studies from Barcelona, Spain, included 23 patients with collagenous colitis and 37 patients with lymphocytic colitis who were identified during a five-year period [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/21\">",
"       21",
"      </a>",
"      ]. Both diseases were more common in women (female:male ratio 4.75 to 1 and 2.7 to 1, for collagenous and lymphocytic colitis, respectively). The mean age at onset of symptoms was 53 for collagenous colitis, and 64 for lymphocytic colitis. The estimated annual incidence per 100,000 inhabitants was 1.1 and 3.1 for collagenous and lymphocytic colitis, respectively. Microscopic colitis was diagnosed at a rate of 9.5 per 100 normal-looking colonoscopies performed in patients with watery diarrhea. In Sweden, the incidence was reported to be even higher [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A higher incidence was observed in a study from Iceland, which identified all pathology reports with the diagnosis of lymphocytic or microscopic colitis between 1995 and 1999 revealing 125 patients (71 with collagenous and 54 with lymphocytic colitis) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/22\">",
"       22",
"      </a>",
"      ]. The mean annual incidence for collagenous and lymphocytic colitis was estimated to be 5.2 and 4.0 per 100,000 inhabitants, respectively. The mean age at diagnosis was 66 and 69 years, respectively.",
"     </li>",
"     <li>",
"      A study from Canada estimated incidence rates of 5.4 per 100,000 person years for lymphocytic colitis and 4.6 per 100,000 person years for collagenous colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/24\">",
"       24",
"      </a>",
"      ]. Women (particularly the elderly) were at increased risk for both collagenous and lymphocytic colitis. An association was also detected between microscopic colitis with celiac disease and hypothyroidism. In addition, the authors observed a previously undescribed association of microscopic colitis with a prior history of malignancy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of the different forms of microscopic colitis is unknown despite a detailed description of their pathology [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/7,9,25-28\">",
"     7,9,25-28",
"    </a>",
"    ]. As noted above, it remains uncertain whether collagenous and lymphocytic colitis are related. The inflammatory cell response is similar in the two disorders (",
"    <a class=\"graphic graphic_table graphicRef58971 \" href=\"UTD.htm?35/35/36411\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/10\">",
"     10",
"    </a>",
"    ]. Furthermore, there is often significant histologic overlap. In one study, colonic biopsy was performed in 30 patients with chronic watery diarrhea and normal radiographic and endoscopic studies: 6 showed lymphocytic colitis alone; 7 showed collagenous colitis alone; and 17 showed a mixed form with both thickening of the collagenous plate and an increased number of intraepithelial lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The extent to which there may be a genetic predisposition to microscopic colitis is unclear. However, familial cases have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Interestingly, different members of the same family developed either lymphocytic or collagenous colitis, supporting a similar underlying pathophysiology.",
"   </p>",
"   <p>",
"    Despite these similarities, other observations suggest some differences between the two conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The female to male ratio is much higher for collagenous colitis compared to lymphocytic colitis (2.4 to 1 in one study with 199 patients) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/15,20,21,32\">",
"       15,20,21,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The histocompatibility phenotypes appear to be different. One study found that HLA-1 was increased and HLA-A3 diminished in patients with lymphocytic colitis, but these changes were not found in patients with collagenous colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Long-term follow-up usually reveals no transformation from one type to another [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/1,34\">",
"       1,34",
"      </a>",
"      ]. One case report, however, described a patient who had collagenous colitis two weeks prior to colectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/35\">",
"       35",
"      </a>",
"      ]. The colectomy specimen revealed loss of the thickened collagen plate with lymphocytic colitis being the predominant finding [",
"      <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Collagenous colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several theories on the etiology of collagenous colitis have been suggested. It is possible that the underlying causes may differ among patients. Collagenous colitis may represent one clinical presentation of a group of collagenous mucosal inflammatory diseases of the gastrointestinal tract that affect not only the colon but also the small intestine and stomach [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Abnormal collagen metabolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal collagen metabolism may be responsible for the thick collagen band in collagenous colitis. The prominent subepithelial matrix deposition appears to be due to an increased expression of the main fibrogenic genes, procollagen I and metalloproteinase inhibitor (TIMP-1), by myofibroblastic cells and inadequate fibrinolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/37-40\">",
"     37-40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One report attempted to determine the biologic composition and origin of these bands by staining the bands using immunohistochemical techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/38\">",
"     38",
"    </a>",
"    ]. The bands stained most prominently for type VI collagen and for the glycoprotein tenascin. There was no significant increase in type VI collagen mRNA expression in the cells around and entrapped in the bands when compared to normal specimens. It was suggested that collagenous colitis is a localized alteration of the extracellular matrix involving the pericryptal subepithelial myofibroblast sheath that resulted from reduced matrix degradation rather than enhanced synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This hypothesis was supported in a study that compared matrix deposition in patients with collagenous colitis to controls [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients with collagenous colitis had restricted matrix metalloproteinase (MMP) 1 and 13 RNA expression and enhanced expression of TIMP-1 (a tissue inhibitor of metalloproteinases). The net effect of these changes would impair fibrinolysis supporting a role for impaired fibrinolysis in the pathogenesis of collagenous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/39\">",
"     39",
"    </a>",
"    ]. In a later case control study, a variation on MMP-9 was significantly associated with collagenous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another study suggested that patients with collagenous colitis have increased expression of transforming growth factor beta 1, which has been associated with the accumulation of collagen in tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/40\">",
"     40",
"    </a>",
"    ]. Transforming growth factor (TGF) beta-1 and vascular endothelial growth factor (VEGF) may influence the balance of local fibrogenesis and fibrinolysis, leading to a net accumulation of immature subepithelial matrix [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The modification of collagen metabolism has also been explained by the expression of endogenous histamine, prostaglandins,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nitric oxide (NO). Increased transcriptional activity of nuclear factor kappa B causes upregulation of inducible nitric oxide synthase activity and, subsequently, increased production of NO in the colonic epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/44\">",
"     44",
"    </a>",
"    ], which might be a direct cause of secretory diarrhea in patients with collagenous colitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Bacterial toxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative hypothesis is that the inflammation and collagen deposition results from bacterial toxins that cause mucosal injury. This theory was supported in a case report in which treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    was associated with resolution in symptoms, normalization of histology, and the reversal of the cytotoxic effects of fecal extracts on an in vitro model [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/45\">",
"     45",
"    </a>",
"    ]. All three parameters worsened when treatment was discontinued, and resolved again upon reinstitution.",
"   </p>",
"   <p>",
"    In addition to binding bacterial toxins, the benefit of bile-acid binding resins may also be related to underlying bile-acid malabsorption, which is common in patients with collagenous colitis. In one study, for example, 12 of 27 patients (44 percent) had an abnormal (75) Se-homocholic acid taurine (75SeHCAT) test [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/46\">",
"     46",
"    </a>",
"    ]. Treatment with a bile-acid binding resin was associated with rapid, marked, or complete improvement in 21 of the patients (78 percent). The cause of bile acid malabsorption in patients with microscopic colitis is unclear since morphologic alterations in the terminal ileum are usually absent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/4,46\">",
"     4,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Synchronous collagenous and pseudomembranous colitis have also been described, suggesting a possible etiologic role for Clostridium difficile in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. Infection with Yersinia sp. has also been suggested as an inciting event for collagenous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/50\">",
"     50",
"    </a>",
"    ]. Resolution of collagenous colitis has been described following treatment for Helicobacter pylori but the association remains unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A role for bacteria in the pathogenesis of this disorder is also supported by the observation that symptoms and histology may improve in patients with lymphocytic colitis after treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     bismuth",
"    </a>",
"    &nbsp;(see",
"    <a class=\"local\" href=\"#H19\">",
"     'Treatment'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     NSAIDs",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been proposed that nonsteroidal antiinflammatory drugs (NSAIDs) are responsible for some cases of microscopic colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/52-58\">",
"     52-58",
"    </a>",
"    ]. One report, for example, compared 31 patients with collagenous colitis to 31 matched controls with irritable bowel syndrome or chronic diverticular disease in whom colonoscopy and biopsy had been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/53\">",
"     53",
"    </a>",
"    ]. Long-term (&gt;6 months) NSAID use was significantly more common among the patients with collagenous colitis (19 versus 4 patients). Among the patients with collagenous colitis and NSAID use, diarrhea followed the use of NSAIDs by a mean of 5.5 years. Three patients improved following withdrawal of NSAIDs; rechallenge in one led to recurrent diarrhea. In another series, however, no association was noted between NSAID use and collagenous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Other drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Collagenous colitis has been linked to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/36/17993?source=see_link\">",
"     simvastatin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/14/3305?source=see_link\">",
"     lansoprazole",
"    </a>",
"    (with associated linear mucosal defects [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/59\">",
"     59",
"    </a>",
"    ]),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"     omeprazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/39/15993?source=see_link\">",
"     esomeprazole",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/27/35255?source=see_link\">",
"     ticlopidine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/60-65\">",
"     60-65",
"    </a>",
"    ], while lymphocytic colitis has been linked to ticlopidine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/23/4470?source=see_link\">",
"     flutamide",
"    </a>",
"    , gold salts, lansoprazole, omeprazole, esomeprazole, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/61,64,66-68\">",
"     61,64,66-68",
"    </a>",
"    ]. The following drugs were considered to have a high likelihood of being a trigger for microscopic colitis in a review of the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/69\">",
"     69",
"    </a>",
"    ]:",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/10/44197?source=see_link\">",
"     acarbose",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , lansoprazole, NSAIDs,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"     ranitidine",
"    </a>",
"    , sertraline, and ticlopidine. Several additional drugs were implicated but the strength of the associations was less clear. Those considered having an intermediate likelihood of being associated with microscopic colitis included:",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , flutamide,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    , and simvastatin. The authors suggested discontinuing or substituting drugs if the timing of introduction suggests a link to the development of symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thickening of the colonic subepithelial collagen band has been found in some diabetic patients with diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/70\">",
"     70",
"    </a>",
"    ]. There was no correlation between collagen thickness, age, and the duration of diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2199622969\">",
"    <span class=\"h3\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking and its effect on colonic blood flow may play a role in the development of MC. In a case-control study that included 340 patients with microscopic colitis, cigarette smoking was associated with the presence of microscopic colitis (odds ratio 2.1, 95% CI 1.6-2.9) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Mechanism of diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;The severity of diarrhea in microscopic colitis correlates with the inflammatory changes in the lamina propria, not with collagen table thickening. Thus, diarrhea probably is caused by the inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/10,15,72\">",
"     10,15,72",
"    </a>",
"    ]. Colonic perfusion studies have shown that the diarrhea is predominantly due to decreased absorption of sodium chloride accompanied by a component of active chloride secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/10,73\">",
"     10,73",
"    </a>",
"    ]. The subepithelial collagenous band acting as a diffusion barrier is a cofactor. Down-regulation of tight junction molecules but not epithelial apoptoses is a structural correlate of barrier dysfunction that contributes to diarrhea by a leak flux mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Collagenous and lymphocytic colitis produce a similar clinical picture characterized by nonbloody chronic watery (secretory) diarrhea of up to two liters daily [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/1,4,7,74\">",
"     1,4,7,74",
"    </a>",
"    ]. The clinical course is mainly intermittent, but is sometimes continuous or rarely consists of a single episode. Affected patients usually produce between four and nine watery stools per day. In a large retrospective study (547 patients with microscopic colitis, 376 patients with lymphocytic colitis, and 171 patients with collagenous colitis), celiac disease (p&lt;0.001), irritable bowel syndrome (p&lt;0.001), and thyroid diseases (p&lt;0.001) were found to have a higher occurrence in microscopic colitis compared to the control group [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3268758125\">",
"    <span class=\"h2\">",
"     Collagenous colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical patient with collagenous colitis is a middle-aged woman in her sixth decade in otherwise good general condition (female-to-male ratio up to 15:1). Collagenous colitis has been reported in children [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/76-78\">",
"     76-78",
"    </a>",
"    ]. Only a slight female preponderance is present in lymphocytic colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/15\">",
"     15",
"    </a>",
"    ]. Accompanying symptoms are variable, and are mostly unspecific and include nausea, vague abdominal pain, and fecal urgency. Extraintestinal symptoms, such as arthralgia, arthritis, or uveitis, can occur (see below).",
"   </p>",
"   <p>",
"    The variability of the clinical presentation and course of the diarrhea can be illustrated by the following findings in a retrospective analysis of 163 patients with collagenous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Onset: Insidious (58 percent); sudden (42 percent)",
"     </li>",
"     <li>",
"      Stools per day: &le;3 (12 percent); 4 to 9 (66 percent); &ge;10 (22 percent); nocturnal diarrhea (27 percent)",
"     </li>",
"     <li>",
"      Associated symptoms: Weight loss (42 percent); abdominal pain (41 percent); fatigue (24 percent)",
"     </li>",
"     <li>",
"      Course: Chronic intermittent (85 percent); chronic continuous (13 percent); single episode (2 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A chronic intermittent course was found in the majority of patients in another report that included 24 patients who were followed for 5 to 16 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/79\">",
"     79",
"    </a>",
"    ]. Many patients had temporary periods in which normal bowel function returned. General health and laboratory parameters remained unaffected. Another series evaluated 47 patients with questionnaires 10 years after diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/80\">",
"     80",
"    </a>",
"    ]. Diarrhea resolved in about one-half of patients with anti-inflammatory treatment and persisted in about one-third of patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3268758139\">",
"    <span class=\"h2\">",
"     Lymphocytic colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term course of patients with lymphocytic colitis may be more favorable than with collagenous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/34,61\">",
"     34,61",
"    </a>",
"    ]. The following observations were made in one series that included 27 patients with lymphocytic colitis who were followed for an average of 38 months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/34\">",
"     34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diarrhea subsided in 93 percent",
"     </li>",
"     <li>",
"      Histologic normalization was seen in 82 percent",
"     </li>",
"     <li>",
"      Progression to collagenous colitis was not observed",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another series compared the natural history in 96 patients with collagenous colitis to 80 patients with lymphocytic colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/61\">",
"     61",
"    </a>",
"    ]. Resolution or significant improvement occurred significantly more often in those with lymphocytic colitis (84 versus 74 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests are non-specific. Slight anemia and elevated erythrocyte sedimentation rate may be seen and autoantibodies are found in approximately one-half of patients. These include rheumatoid factor, antinuclear and antimitochondrial antibodies, and ANCA [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/4,6,14,81\">",
"     4,6,14,81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Stool examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data regarding the use of fecal markers for collagenous colitis are limited. Increased levels of the inflammatory markers eosinophil protein X (EPX), myeloperoxidase (MPO), and tryptase have been detected in stool from patients with collagenous colitis whereas the levels in patients with irritable bowel syndrome did not differ from healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/82\">",
"     82",
"    </a>",
"    ]. The authors suggested that fecal markers could be used as part of the clinical work-up to determine which patients should be biopsied and evaluated for collagenous colitis, an approach that requires further validation.",
"   </p>",
"   <p>",
"    A study of 46 patients compared the excretion of the inflammatory and metabolic fecal markers calprotectin, lactoferrin, and short-chain fatty acids among patients with active collagenous colitis, quiescent collagenous colitis, and controls [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/83\">",
"     83",
"    </a>",
"    ]. The median calprotectin level was increased in patients with active collagenous colitis compared with patients with quiescent collagenous colitis and controls (80",
"    <span class=\"nowrap\">",
"     mcg/g",
"    </span>",
"    stool weight versus 26",
"    <span class=\"nowrap\">",
"     mcg/g",
"    </span>",
"    and 6",
"    <span class=\"nowrap\">",
"     mcg/g,",
"    </span>",
"    respectively). Lactoferrin was detected in only one patient. The concentration of total short-chain fatty acids did not differ among the groups, but concentrations of the branched-chain fatty acids were decreased in patients with active collagenous colitis compared with controls (p&lt;0.005).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term microscopic colitis implies that the diagnosis is made by histology. Thus, colonoscopy usually reveals macroscopically normal colonic mucosa, although slight edema, erythema, and friability may be seen. In small case series, chromoendoscopy using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15522?source=see_link\">",
"     indigo carmine",
"    </a>",
"    highlighted mucosal alterations that correspond to the histological distribution of microscopic colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/84\">",
"     84",
"    </a>",
"    ]. However, larger studies are needed before routine use of chromoendoscopy can be recommended for the diagnosis of microscopic colitis.",
"   </p>",
"   <p>",
"    Although specimens obtained by flexible sigmoidoscopy are frequently sufficient to establish the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/85\">",
"     85",
"    </a>",
"    ], the severity of histologic changes declines from the proximal to the distal colon; thus, biopsies obtained from the right colon are optimal. Collagenous colitis can be patchy, with normal mucosa being found mainly in specimens from the rectosigmoid. In several reports, rectosigmoid biopsies alone would have missed the diagnosis of collagenous colitis in up to 40 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/25,86\">",
"     25,86",
"    </a>",
"    ]. In a retrospective analysis of histologic specimens from 56 patients, the highest diagnostic yield was achieved in biopsies from the transverse colon (83 percent) and right colon (70 percent), and lowest in the rectosigmoid (66 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/87\">",
"     87",
"    </a>",
"    ]. Thus, total colonoscopy is necessary to establish the diagnosis of collagenous colitis and to exclude other inflammatory diseases. While colonoscopy is generally safe in such patients, an increasing number of perforations have been described in patients with severe collagen deposits (\"fractured colon\") [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/88-90\">",
"     88-90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Collagen band",
"    </span>",
"    &nbsp;&mdash;&nbsp;The histologic characteristics of microscopic colitis are heterogeneous and include both classic and \"atypical\" forms in which the histologic findings resemble those more typically seen in inflammatory bowel disease, chronic ischemia, or infectious colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/91\">",
"     91",
"    </a>",
"    ]. Collagenous colitis is classically characterized by colonic mucosal subepithelial collagen deposition of 7 to 100 &micro;m (normal range: 1 to 7 &micro;m) in diameter (",
"    <a class=\"graphic graphic_picture graphicRef60570 graphicRef74390 \" href=\"UTD.htm?40/2/41002\">",
"     picture 1A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/10\">",
"     10",
"    </a>",
"    ]. In a systematic computer-assisted study, the collagen table thickness was measured 20 times per biopsy in six specimens obtained from six areas throughout the colon. The average collagen table thickness was significantly higher in the patients with collagenous colitis (4.4 to 18.5 &micro;m versus 2.8 &micro;m in normal controls) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/10\">",
"     10",
"    </a>",
"    ]. In some cases, the increase in colonic wall thickness can be detected by ultrasonography (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79824 \" href=\"UTD.htm?17/50/18208\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Thickened collagen tables are not entirely specific for collagenous colitis. One report described a 69-year-old woman with histopathologic features of collagenous colitis throughout a colectomy specimen; colectomy was performed because of life-long intractable idiopathic constipation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/92\">",
"     92",
"    </a>",
"    ]. This patient had never suffered from episodes of watery diarrhea. This finding is compatible with the observation that the watery diarrhea in microscopic colitis is primarily due to intestinal inflammation rather than increased collagen deposition [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/10,15\">",
"     10,15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Mechanism of diarrhea'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Intraepithelial lymphocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inflammatory cell response is often similar in lymphocytic and collagenous colitis, consisting mainly of mononuclear infiltrates with few neutrophils and eosinophils in the lamina propria (",
"    <a class=\"graphic graphic_picture graphicRef54897 \" href=\"UTD.htm?39/3/39993\">",
"     picture 2",
"    </a>",
"    ). The number of intraepithelial lymphocytes (IEL) is often above 20 per 100 epithelial cells; normal IEL counts (3 to 5 per 100 epithelial cells) indicate low activity and milder symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/1\">",
"     1",
"    </a>",
"    ]. Crypt architecture is usually not distorted, but focal cryptitis may be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ASSOCIATION WITH SMALL BOWEL AND OTHER DISEASES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with microscopic colitis only rarely have laboratory evidence of small bowel involvement with associated malabsorption or protein-losing enteropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/93-95\">",
"     93-95",
"    </a>",
"    ]. The simultaneous occurrence of lymphocytic colitis and lymphocytic gastritis has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/96\">",
"     96",
"    </a>",
"    ]. Focal areas of microscopic colitis have also been described in patients with established inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/97-101\">",
"     97-101",
"    </a>",
"    ]. They may also precede the development of overt clinical and histopathologic evidence of inflammatory bowel disease (particularly Crohn's disease), although colonoscopic abnormalities are frequently present providing a clue toward the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/97-101\">",
"     97-101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An association between microscopic colitis and celiac disease has been observed [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/93,102-109\">",
"     93,102-109",
"    </a>",
"    ]. Furthermore, collagenous enterocolitis may represent a diffuse manifestation of gluten sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/107,110\">",
"     107,110",
"    </a>",
"    ]. Thus, it is reasonable to test patients for celiac disease. The HLA-DR3-DQ2 haplotype which predisposes for celiac disease is more frequent in patients with lymphocytic colitis as well as in patients with collagenous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/111,112\">",
"     111,112",
"    </a>",
"    ]. Microscopic colitis demonstrates a T(H)1 mucosal cytokine profile with upregulated interferon gamma and interleukin 15, tumor necrosis factor, and nitric oxide synthase. This pattern is similar to that in celiac disease and might indicate response to a luminal antigen [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/113\">",
"     113",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=see_link\">",
"     \"Diagnosis of celiac disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is also evidence in some patients that collagenous colitis is a systemic disorder. In one report, concomitant autoimmune diseases were more common in collagenous compared with lymphocytic colitis (53 versus 26 percent), while celiac disease was common in both disorders (20 versus 15 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/114\">",
"     114",
"    </a>",
"    ]. Among the extraintestinal manifestations that have been described are a nonerosive, oligoarticular arthritis and thyroiditis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/81\">",
"     81",
"    </a>",
"    ]. A case report demonstrated venulitis in a 79-year-old man who underwent a subtotal colectomy due to transfusion-dependent occult bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/115\">",
"     115",
"    </a>",
"    ]. Prominent lymphocytic venulitis was present in the proximal colon, gradually merging into lymphocytic and collagenous colitis distally. Another case report described a patient with collagenous gastrobulbitis in association with collagenous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/116\">",
"     116",
"    </a>",
"    ]. Whether these associations reflect an autoimmune pathogenesis of microscopic colitis is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of microscopic colitis has been based mainly on observational data; the few controlled trials that exist have mainly evaluated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    , a glucocorticoid that has high affinity for the glucocorticoid receptor but low systemic activity due to extensive first-pass hepatic metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/117,118\">",
"     117,118",
"    </a>",
"    ]. A meta-analysis of controlled therapeutic trials made the following conclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/119\">",
"     119",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Of 10 randomized studies in collagenous colitis, the pooled odds ratio for inducing a clinical response with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      was 12.32 (95% CI 5.53-27.46) and for maintaining a clinical response was 8.82 (95% CI 3.19-24.37). There were limited data for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"       bismuth",
"      </a>",
"      subsalicylate,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=see_link\">",
"       mesalamine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"       cholestyramine",
"      </a>",
"      , although there was some evidence of efficacy. There was no evidence for a benefit from probiotics or an extract of the herb Boswellia serrata.",
"     </li>",
"     <li>",
"      Of three randomized studies in patients with lymphocytic colitis, one evaluated",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      and found it effective for inducing a clinical response (OR 9.0, 95% CI 1.98-40.93). There was some evidence for efficacy of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"       bismuth",
"      </a>",
"      subsalicylate,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=see_link\">",
"       mesalamine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"       cholestyramine",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The treatment for patients with drug-induced microscopic colitis is to stop the responsible drug [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/120\">",
"     120",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be reassured, since microscopic colitis has not been associated with increased mortality or severe deterioration. Diarrhea may resolve within weeks with or without treatment, but relapses are common (approximately 30 to 60 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/25,66,121,122\">",
"     25,66,121,122",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Therapy for both collagenous and lymphocytic colitis should consist of stopping NSAIDs and other drugs that have been associated with these disorders (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Other drugs'",
"    </a>",
"    above). Patients diagnosed with celiac disease should be placed on a gluten-free diet. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4714?source=see_link\">",
"     \"Management of celiac disease in adults\"",
"    </a>",
"    .) Concomitant irritable bowel syndrome may contribute to symptoms and patients may benefit from its treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/123,124\">",
"     123,124",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40169?source=see_link\">",
"     \"Treatment of irritable bowel syndrome\"",
"    </a>",
"    .) Treatment of diarrhea can also be helpful; our first choice for antidiarrheal therapy is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"     loperamide",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3268758146\">",
"    <span class=\"h3\">",
"     Budesonide",
"    </span>",
"    &nbsp;&mdash;&nbsp;If symptoms persist despite the above measures, we recommend",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    . Controlled trials in patients with collagenous colitis suggested that budesonide is effective at least for short-term treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/119,122,125-127\">",
"     119,122,125-127",
"    </a>",
"    ]. It can also improve quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/128\">",
"     128",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An illustrative trial included 51 patients who were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    (9",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for six weeks) or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/126\">",
"     126",
"    </a>",
"    ]. Significantly more patients who received budesonide were in clinical remission at the end of the study (87 versus 14 percent).Clinical remission was observed within two weeks in 60 percent of patients and after four to six weeks in 85 percent of patients in one of the studies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/129\">",
"     129",
"    </a>",
"    ]. The median time to clinical remission was 12 days. The authors concluded that a treatment duration of six weeks appeared to be optimal but a shorter duration of treatment may be sufficient. A meta-analysis of eight randomized trials that included 248 patients randomized to glucocorticoids versus placebo found that budesonide was significantly more effective than placebo for short-term clinical response (RR 3.1; 95% CI 2.1-4.6) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/130\">",
"     130",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The long-term benefit of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    has not been well studied but relapse appears to be common after it is stopped. A placebo-controlled crossover study found that relapse occurred in 61 percent of patients within two weeks of placebo treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/122\">",
"     122",
"    </a>",
"    ]. Relapse was more likely in those younger than 60. Interestingly, the histologic response of the colonic mucosa does not seem to parallel the therapeutic response in all cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only limited data are available that have described the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    for maintenance therapy in collagenous colitis. The available data suggest that long-term maintenance therapy is needed to maintain remission in most patients. Long-term treatment with budesonide increases the risk of steroid-related side effects. A pooled analysis included two maintenance budesonide trials with a six-week, open-label induction phase, followed by a six-month, double-blind maintenance phase of 6 mg of budesonide daily versus placebo, in patients with collagenous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/130\">",
"     130",
"    </a>",
"    ]. In this analysis, long-term treatment with budesonide was significantly superior to placebo for maintenance of clinical response (RR 3.2; 95% CI, 1.1&ndash;9.9). Relapse occurred in 46 to 80 percent of patients within six months of treatment cessation.",
"   </p>",
"   <p>",
"    Little is known about treatment options in children [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/131\">",
"     131",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is less experience with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    in lymphocytic colitis, although a similar benefit was described in a controlled trial involving 41 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/132\">",
"     132",
"    </a>",
"    ]. The rate of complete remission at six weeks was 86 versus 40 percent. Its benefit for long-term maintenance of remission has not been well studied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3273552015\">",
"    <span class=\"h3\">",
"     Aminosalicylate/sulfasalazine",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with collagenous or lymphocytic colitis who do not improve with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    , we try an aminosalicylate or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/55,133,134\">",
"     55,133,134",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20344?source=see_link\">",
"     \"Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease\"",
"    </a>",
"    .)&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"     Loperamide",
"    </a>",
"    can be added for symptomatic relief.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3273552022\">",
"    <span class=\"h3\">",
"     Cholestyramine",
"    </span>",
"    &nbsp;&mdash;&nbsp;If an aminosalicylate is not effective, we initiate a short trial of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    (4 g four times per day) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/46\">",
"     46",
"    </a>",
"    ]. If cholestyramine is not effective, we switch to glucocorticoids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3268758153\">",
"    <span class=\"h3\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     Prednisone",
"    </a>",
"    (eg, 0.5 to 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    body weight per day) leads to a reduction in colonic inflammation but not in the thickness of the collagen band [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/76,135,136\">",
"     76,135,136",
"    </a>",
"    ]. As compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    , prednisone is associated with a lower response rate, more side effects, and a higher risk of relapse when therapy is withdrawn [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/136,137\">",
"     136,137",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3268758160\">",
"    <span class=\"h3\">",
"     Bismuth subsalicylate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another approach is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     bismuth",
"    </a>",
"    subsalicylate, which is used mainly in the United States. In an open label study, treatment was associated with improvement in symptoms in 11 of 13 patients and resolution of colitis in nine [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/138\">",
"     138",
"    </a>",
"    ]. These results were confirmed in a subsequent preliminary trial in which 14 patients were randomly assigned to receive bismuth subsalicylate (three 262 mg chewable tablets three times daily) or placebo for eight weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/139\">",
"     139",
"    </a>",
"    ]. Compared to placebo, treatment was associated with a significant decrease in fecal frequency and weight, and improvement in consistency. In addition, colonic histology improved more often in treated patients (57 versus 17 percent) and returned to normal in two patients. These improvements were also observed in six patients initially taking placebo who were crossed over to treatment. The benefit of therapy persisted for one to eight months in nine patients after stopping therapy. One patient discontinued therapy due to nausea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31688217\">",
"    <span class=\"h3\">",
"     Other therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;A gluten-free diet should be considered in patients unresponsive to medical treatment because of a possible association of microscopic colitis with gluten sensitivity even in the absence of overt celiac disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4714?source=see_link&amp;anchor=H7321264#H7321264\">",
"     \"Management of celiac disease in adults\", section on 'Components of the gluten-free diet'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although a number of other therapies have been effective in treating small series of patients with refractory microscopic colitis, additional studies are needed before they can be recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/119\">",
"     119",
"    </a>",
"    ]. Treatment regimens have included",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    (400 mg three times daily),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    (50 to 100 mcg every eight hours subcutaneously),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"     mercaptopurine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    , anti-tumor necrosis factor-alpha inhibitors (anti-TNFs), probiotic E. coli strain Nissle, and Boswellia serrata extract [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/3,140-145\">",
"     3,140-145",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other causes of diarrhea should be excluded in patients with microscopic colitis who fail to respond to medical therapy. These include celiac disease, hyperthyroidism, carcinoid syndrome, VIPoma, and persistent NSAID use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnosis of celiac disease\", section on 'Diagnostic approach'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26520?source=see_link\">",
"     \"Diagnosis of hyperthyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=see_link\">",
"     \"Diagnosis of the carcinoid syndrome and tumor localization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/59/16311?source=see_link\">",
"     \"The VIPoma syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26406?source=see_link\">",
"     \"NSAIDs: Adverse effects on the distal small bowel and colon\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Natural history after medical treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few prospective studies have examined the natural history of microscopic colitis in patients who received the medical treatments described above. One of the largest such studies included 37 patients with collagenous and 44 patients with lymphocytic colitis who were followed prospectively after diagnosis for an average of 37 months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/66\">",
"     66",
"    </a>",
"    ]. Patients were treated with a variety of interventions, including withdrawal of implicated medications and the use of salicylates,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    . These interventions were associated with long-term cessation of diarrhea in approximately 70 percent of patients, while 25 to 30 percent relapsed. Microscopic colitis has not been associated with an increased risk of colorectal cancer. As noted above, relapse appears to be common after treatment with budesonide. (See",
"    <a class=\"local\" href=\"#H3268758146\">",
"     'Budesonide'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery (ileostomy, sigmoidostomy, colectomy) has rarely been reported in microscopic colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/35,121,146,147\">",
"     35,121,146,147",
"    </a>",
"    ]. Ileostomy may be the procedure of choice in older patients with resistant disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/1,146\">",
"     1,146",
"    </a>",
"    ]. In one series of patients with collagenous colitis with severe diarrhea refractory to medical therapy, ileostomy was performed in eight patients and sigmoidostomy in one [",
"    <a class=\"abstract\" href=\"UTD.htm?26/56/27530/abstract/146\">",
"     146",
"    </a>",
"    ]. Postoperatively, the diarrhea ceased in all patients and the collagen layer was reduced to normal throughout the colon following ileostomy and in the excluded colon following sigmoidostomy. The findings suggest that fecal stream diversion eliminates noxious luminal factors which seem to be of pathogenetic importance at least in patients with refractory disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/36/25154?source=see_link\">",
"       \"Patient information: Microscopic colitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microscopic colitis is characterized by chronic watery (secretory) diarrhea without bleeding. It usually occurs in middle-aged patients, but can affect children. The colon appears normal by colonoscopy or computed tomographic (CT) colonography. The diagnosis is established by biopsy of the colonic mucosa which reveals colitis, but not mucosal ulcerations.",
"   </p>",
"   <p>",
"    Two different types of microscopic colitis are generally recognized:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lymphocytic colitis",
"     </li>",
"     <li>",
"      Collagenous colitis without lymphocytic infiltration of the surface epithelium",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Therapeutic options are based mainly upon controlled trials of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    , limited reports of other approaches in small numbers of patients, and an appreciation of the natural history.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients should be reassured since microscopic colitis has not been associated with increased mortality or severe deterioration.",
"     </li>",
"     <li>",
"      Drugs known to be associated with microscopic colitis (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Other drugs'",
"      </a>",
"      above) should be discontinued.",
"     </li>",
"     <li>",
"      Patients should be tested for celiac disease; a gluten-free diet should be recommended if the diagnosis is established.",
"     </li>",
"     <li>",
"      For patients with lymphocytic or collagenous colitis with troubling symptoms, we recommend",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We usually give 9",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      for four weeks. If the patient is in remission, we taper to 6 mg for two weeks, to 3 mg for another two weeks, and then discontinue therapy. If the symptoms are not controlled or if symptoms recur on tapering, the dose of 9 mg can be continued for 12 weeks or longer before tapering budesonide. (See",
"      <a class=\"local\" href=\"#H3268758146\">",
"       'Budesonide'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who do not respond to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      , we suggest a short course of aminosalicylate (up to 1.5 g three times per day) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If an aminosalicylate is not effective, we suggest a short trial of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"       cholestyramine",
"      </a>",
"      (4 g four times per day) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3273552015\">",
"       'Aminosalicylate/sulfasalazine'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3273552022\">",
"       'Cholestyramine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"       cholestyramine",
"      </a>",
"      is not effective, we suggest a trial of systemic glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). An alternative may be a trial of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"       bismuth",
"      </a>",
"      subsalicylate, which is used mainly in the United States. (See",
"      <a class=\"local\" href=\"#H3268758153\">",
"       'Glucocorticoids'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3268758160\">",
"       'Bismuth subsalicylate'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other causes of diarrhea should be excluded in patients with microscopic colitis who fail to respond to medical therapy. A gluten-free diet should be considered in patients unresponsive to medical treatment because of a possible association of microscopic colitis with gluten sensitivity even in the absence of overt celiac disease. (See",
"      <a class=\"local\" href=\"#H31688217\">",
"       'Other therapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/1\">",
"      Veress B, L&ouml;fberg R, Bergman L. Microscopic colitis syndrome. Gut 1995; 36:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/2\">",
"      Lindstr&ouml;m CG. 'Collagenous colitis' with watery diarrhoea--a new entity? Pathol Eur 1976; 11:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/3\">",
"      Kingham JG. Microscopic colitis. Gut 1991; 32:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/4\">",
"      Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/5\">",
"      Bohr J, Tysk C, Eriksson S, J&auml;rnerot G. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut 1995; 37:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/6\">",
"      Giardiello FM, Bayless TM, Jessurun J, et al. Collagenous colitis: physiologic and histopathologic studies in seven patients. Ann Intern Med 1987; 106:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/7\">",
"      Giardiello FM, Lazenby AJ, Bayless TM. The new colitides, Collagenous, lymphocytic, and diversion colitis. Gastroenterol Clin North Am 1995; 24:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/8\">",
"      Giardiello FM, Lazenby AJ, Bayless TM, et al. Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci 1989; 34:1730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/9\">",
"      Jessurun J, Yardley JH, Giardiello FM, et al. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol 1987; 18:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/10\">",
"      Lee E, Schiller LR, Vendrell D, et al. Subepithelial collagen table thickness in colon specimens from patients with microscopic colitis and collagenous colitis. Gastroenterology 1992; 103:1790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/11\">",
"      Mills LR, Schuman BM, Thompson WO. Lymphocytic colitis. A definable clinical and histological diagnosis. Dig Dis Sci 1993; 38:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/12\">",
"      Kayaselcuk F, Serin E, Gumurdulu Y, et al. Subepithelial basement membrane thickness in patients with normal colonic mucosal appearance in colonoscopy: results from southern Turkey. World J Gastroenterol 2004; 10:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/13\">",
"      Jessurun J, Yardley JH, Lee EL, et al. Microscopic and collagenous colitis: different names for the same condition? Gastroenterology 1986; 91:1583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/14\">",
"      Sylwestrowicz T, Kelly JK, Hwang WS, Shaffer EA. Collagenous colitis and microscopic colitis: the watery diarrhea-colitis syndrome. Am J Gastroenterol 1989; 84:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/15\">",
"      Jackson BK. Are collagenous colitis and lymphocytic colitis distinct syndromes? Dig Dis 1995; 13:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/16\">",
"      Clouse RE, Alpers DH, Hockenbery DM, DeSchryver-Kecskemeti K. Pericrypt eosinophilic enterocolitis and chronic diarrhea. Gastroenterology 1992; 103:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/17\">",
"      Baum CA, Bhatia P, Miner PB Jr. Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis. Dig Dis Sci 1989; 34:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/18\">",
"      Vesoulis Z, Lozanski G, Ravichandran P, Esber E. Collagenous gastritis: a case report, morphologic evaluation, and review. Mod Pathol 2000; 13:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/19\">",
"      Sapp H, Ithamukkala S, Brien TP, et al. The terminal ileum is affected in patients with lymphocytic or collagenous colitis. Am J Surg Pathol 2002; 26:1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/20\">",
"      Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 2004; 53:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/21\">",
"      Fern&aacute;ndez-Ba&ntilde;ares F, Salas A, Forn&eacute; M, et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 1999; 94:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/22\">",
"      Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 2002; 47:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/23\">",
"      Pardi DS, Loftus EV Jr, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007; 56:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/24\">",
"      Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol 2008; 6:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/25\">",
"      Carpenter HA, Tremaine WJ, Batts KP, Czaja AJ. Sequential histologic evaluations in collagenous colitis. Correlations with disease behavior and sampling strategy. Dig Dis Sci 1992; 37:1903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/26\">",
"      Lazenby AJ, Yardley JH, Giardiello FM, Bayless TM. Pitfalls in the diagnosis of collagenous colitis: experience with 75 cases from a registry of collagenous colitis at the Johns Hopkins Hospital. Hum Pathol 1990; 21:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/27\">",
"      Widgren S, Jlidi R, Cox JN. Collagenous colitis: histologic, morphometric, immunohistochemical and ultrastructural studies. Report of 21 cases. Virchows Arch A Pathol Anat Histopathol 1988; 413:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/28\">",
"      Zins BJ, Tremaine WJ, Carpenter HA. Collagenous colitis: mucosal biopsies and association with fecal leukocytes. Mayo Clin Proc 1995; 70:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/29\">",
"      Abdo AA, Zetler PJ, Halparin LS. Familial microscopic colitis. Can J Gastroenterol 2001; 15:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/30\">",
"      J&auml;rnerot G, Hertervig E, Gr&auml;nn&ouml; C, et al. Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol 2001; 36:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/31\">",
"      van Tilburg AJ, Lam HG, Seldenrijk CA, et al. Familial occurrence of collagenous colitis. A report of two families. J Clin Gastroenterol 1990; 12:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/32\">",
"      Olesen M, Eriksson S, Bohr J, et al. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004; 53:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/33\">",
"      Giardiello FM, Lazenby AJ, Yardley JH, et al. Increased HLA A1 and diminished HLA A3 in lymphocytic colitis compared to controls and patients with collagenous colitis. Dig Dis Sci 1992; 37:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/34\">",
"      Mullhaupt B, G&uuml;ller U, Anabitarte M, et al. Lymphocytic colitis: clinical presentation and long term course. Gut 1998; 43:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/35\">",
"      Bowling TE, Price AB, al-Adnani M, et al. Interchange between collagenous and lymphocytic colitis in severe disease with autoimmune associations requiring colectomy: a case report. Gut 1996; 38:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/36\">",
"      Freeman HJ. Collagenous mucosal inflammatory diseases of the gastrointestinal tract. Gastroenterology 2005; 129:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/37\">",
"      Daum S, Foss HD, Schuppan D, et al. Synthesis of collagen I in collagenous sprue. Clin Gastroenterol Hepatol 2006; 4:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/38\">",
"      Aigner T, Neureiter D, M&uuml;ller S, et al. Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology 1997; 113:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/39\">",
"      G&uuml;nther U, Schuppan D, Bauer M, et al. Fibrogenesis and fibrolysis in collagenous colitis. Patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1 gene expression. Am J Pathol 1999; 155:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/40\">",
"      St&aring;hle-B&auml;ckdahl M, Maim J, Veress B, et al. Increased presence of eosinophilic granulocytes expressing transforming growth factor-beta1 in collagenous colitis. Scand J Gastroenterol 2000; 35:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/41\">",
"      Madisch A, Miehlke S, Schreiber S, et al. Matrix metalloproteinase-9 gene polymorphism is associated with collagenous colitis. Gut 2006; 55:A113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/42\">",
"      Griga T, Tromm A, Schmiegel W, et al. Collagenous colitis: implications for the role of vascular endothelial growth factor in repair mechanisms. Eur J Gastroenterol Hepatol 2004; 16:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/43\">",
"      Taha Y, Raab Y, Larsson A, et al. Vascular endothelial growth factor (VEGF)--a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis. Dig Dis Sci 2004; 49:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/44\">",
"      Andresen L, J&oslash;rgensen VL, Perner A, et al. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 2005; 54:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/45\">",
"      Andersen T, Andersen JR, Tvede M, Franzmann MB. Collagenous colitis: are bacterial cytotoxins responsible? Am J Gastroenterol 1993; 88:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/46\">",
"      Ung KA, Gillberg R, Kilander A, Abrahamsson H. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 2000; 46:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/47\">",
"      Khan MA, Brunt EM, Longo WE, Presti ME. Persistent Clostridium difficile colitis: a possible etiology for the development of collagenous colitis. Dig Dis Sci 2000; 45:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/48\">",
"      Treanor D, Gibbons D, O' Donoghue DP, Sheahan K. Pseudomembranes in collagenous colitis. Histopathology 2001; 38:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/49\">",
"      Vesoulis Z, Lozanski G, Loiudice T. Synchronous occurrence of collagenous colitis and pseudomembranous colitis. Can J Gastroenterol 2000; 14:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/50\">",
"      Bohr J, Nordfelth R, J&auml;rnerot G, Tysk C. Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol 2002; 37:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/51\">",
"      Narayani RI, Burton MP, Young GS. Resolution of collagenous colitis after treatment for Helicobacter pylori. Am J Gastroenterol 2002; 97:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/52\">",
"      Giardiello FM, Hansen FC 3rd, Lazenby AJ, et al. Collagenous colitis in setting of nonsteroidal antiinflammatory drugs and antibiotics. Dig Dis Sci 1990; 35:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/53\">",
"      Riddell RH, Tanaka M, Mazzoleni G. Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 1992; 33:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/54\">",
"      Stampfl DA, Friedman LS. Collagenous colitis: pathophysiologic considerations. Dig Dis Sci 1991; 36:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/55\">",
"      Katanuma A, Kodama T, Tamaki T, et al. Collagenous colitis. Intern Med 1995; 34:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/56\">",
"      Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104:1832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/57\">",
"      P&uuml;sp&ouml;k A, Kiener HP, Oberhuber G. Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum 2000; 43:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/58\">",
"      Keszthelyi D, Penders J, Masclee AA, Pierik M. Is microscopic colitis a drug-induced disease? J Clin Gastroenterol 2012; 46:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/59\">",
"      Nomura E, Kagaya H, Uchimi K, et al. Linear mucosal defects: a characteristic endoscopic finding of lansoprazole-associated collagenous colitis. Endoscopy 2010; 42 Suppl 2:E9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/60\">",
"      Wilcox GM, Mattia A. Collagenous colitis associated with lansoprazole. J Clin Gastroenterol 2002; 34:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/61\">",
"      Baert F, Wouters K, D'Haens G, et al. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 1999; 45:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/62\">",
"      Feurle GE, Bartz KO, Schmitt-Gr&auml;ff A. Lymphocytic colitis, induced by ticlopidine. Z Gastroenterol 1999; 37:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/63\">",
"      Chande N, Driman DK. Microscopic colitis associated with lansoprazole: report of two cases and a review of the literature. Scand J Gastroenterol 2007; 42:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/64\">",
"      Wilcox GM, Mattia AR. Microscopic colitis associated with omeprazole and esomeprazole exposure. J Clin Gastroenterol 2009; 43:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/65\">",
"      Keszthelyi D, Jansen SV, Schouten GA, et al. Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study. Aliment Pharmacol Ther 2010; 32:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/66\">",
"      Fern&aacute;ndez-Ba&ntilde;ares F, Salas A, Esteve M, et al. Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003; 98:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/67\">",
"      Thomson RD, Lestina LS, Bensen SP, et al. Lansoprazole-associated microscopic colitis: a case series. Am J Gastroenterol 2002; 97:2908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/68\">",
"      Fern&aacute;ndez-Ba&ntilde;ares F, Esteve M, Espin&oacute;s JC, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007; 102:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/69\">",
"      Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis - proposal for a scoring system and review of the literature. Aliment Pharmacol Ther 2005; 22:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/70\">",
"      Kandemir O, Utas C, G&ouml;nen O, et al. Colonic subepithelial collagenous thickening in diabetic patients. Dis Colon Rectum 1995; 38:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/71\">",
"      Yen EF, Pokhrel B, Du H, et al. Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis 2012; 18:1835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/72\">",
"      Tremaine WJ. Diagnosing collagenous colitis: does it make a difference? Eur J Gastroenterol Hepatol 1999; 11:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/73\">",
"      B&uuml;rgel N, Bojarski C, Mankertz J, et al. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002; 123:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/74\">",
"      Zins BJ, Sandborn WJ, Tremaine WJ. Collagenous and lymphocytic colitis: subject review and therapeutic alternatives. Am J Gastroenterol 1995; 90:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/75\">",
"      Kao KT, Pedraza BA, McClune AC, et al. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol 2009; 15:3122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/76\">",
"      Gremse DA, Boudreaux CW, Manci EA. Collagenous colitis in children. Gastroenterology 1993; 104:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/77\">",
"      Yardley JH, Lazenby AJ, Kornacki S. Collagenous colitis in children. Gastroenterology 1993; 105:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/78\">",
"      J&oacute;zefczuk J, Wozniewicz BM. Clear cell colitis: a form of microscopic colitis in children. World J Gastroenterol 2008; 14:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/79\">",
"      Bonderup OK, Folkersen BH, Gjers&oslash;e P, Teglbjaerg PS. Collagenous colitis: a long-term follow-up study. Eur J Gastroenterol Hepatol 1999; 11:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/80\">",
"      Madisch A, Miehlke S, Lindner M, et al. Clinical course of collagenous colitis over a period of 10 years. Z Gastroenterol 2006; 44:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/81\">",
"      Kingsmore SF, Kingsmore DB, Hall BD, et al. Cooccurrence of collagenous colitis with seronegative spondyloarthropathy: report of a case and literature review. J Rheumatol 1993; 20:2153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/82\">",
"      Lettesj&ouml; H, Hansson T, Peterson C, et al. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis. Scand J Gastroenterol 2006; 41:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/83\">",
"      Wildt S, Nordgaard-Lassen I, Bendtsen F, Rumessen JJ. Metabolic and inflammatory faecal markers in collagenous colitis. Eur J Gastroenterol Hepatol 2007; 19:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/84\">",
"      Suzuki G, Mellander MR, Suzuki A, et al. Usefulness of colonoscopic examination with indigo carmine in diagnosing microscopic colitis. Endoscopy 2011; 43:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/85\">",
"      Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc 2000; 51:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/86\">",
"      Tanaka M, Mazzoleni G, Riddell RH. Distribution of collagenous colitis: utility of flexible sigmoidoscopy. Gut 1992; 33:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/87\">",
"      Surawicz CM. Collating collagenous colitis cases. Am J Gastroenterol 2000; 95:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/88\">",
"      Sherman A, Ackert JJ, Rajapaksa R, et al. Fractured colon: an endoscopically distinctive lesion associated with colonic perforation following colonoscopy in patients with collagenous colitis. J Clin Gastroenterol 2004; 38:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/89\">",
"      Allende DS, Taylor SL, Bronner MP. Colonic perforation as a complication of collagenous colitis in a series of 12 patients. Am J Gastroenterol 2008; 103:2598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/90\">",
"      Hussain Z, Kelly S, Clarke A, et al. Colonic perforation in collagenous colitis: a systematic review of a rare complication and guidance on management. Surg Endosc 2010; 24:2930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/91\">",
"      Chang F, Deere H, Vu C. Atypical forms of microscopic colitis: morphological features and review of the literature. Adv Anat Pathol 2005; 12:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/92\">",
"      Leigh C, Elahmady A, Mitros FA, et al. Collagenous colitis associated with chronic constipation. Am J Surg Pathol 1993; 17:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/93\">",
"      Hamilton I, Sanders S, Hopwood D, Bouchier IA. Collagenous colitis associated with small intestinal villous atrophy. Gut 1986; 27:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/94\">",
"      Lewis FW, Warren GH, Goff JS. Collagenous colitis with involvement of terminal ileum. Dig Dis Sci 1991; 36:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/95\">",
"      Stark ME, Batts KP, Alexander GL. Protein-losing enteropathy with collagenous colitis. Am J Gastroenterol 1992; 87:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/96\">",
"      Christ AD, Meier R, Bauerfeind P, et al. [Simultaneous occurrence of lymphocytic gastritis and lymphocytic colitis with transition to collagenous colitis]. Schweiz Med Wochenschr 1993; 123:1487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/97\">",
"      Chandratre S, Bramble MG, Cooke WM, Jones RA. Simultaneous occurrence of collagenous colitis and Crohn's disease. Digestion 1987; 36:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/98\">",
"      Chutkan R, Sternthal M, Janowitz HD. A family with collagenous colitis, ulcerative colitis, and Crohn's disease. Am J Gastroenterol 2000; 95:3640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/99\">",
"      Goldblum JR, Wang N. Lymphocytic and collagenous colitis as possible patterns of Crohn's colitis. Am J Surg Pathol 2000; 24:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/100\">",
"      Melato M, Perazza L, Buri L. Collagenous colitis and Crohn's disease: unrelated? Ital J Gastroenterol 1996; 28:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/101\">",
"      Goldstein NS, Gyorfi T. Focal lymphocytic colitis and collagenous colitis: patterns of Crohn's colitis? Am J Surg Pathol 1999; 23:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/102\">",
"      O'Mahony S, Nawroz IM, Ferguson A. Coeliac disease and collagenous colitis. Postgrad Med J 1990; 66:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/103\">",
"      Gillett HR, Freeman HJ. Prevalence of celiac disease in collagenous and lymphocytic colitis. Can J Gastroenterol 2000; 14:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/104\">",
"      Barbato M, Viola F, Russo LL, et al. Microscopic and collagenous colitis in treated celiac disease due to food allergy? Gastroenterology 1999; 116:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/105\">",
"      DuBois RN, Lazenby AJ, Yardley JH, et al. Lymphocytic enterocolitis in patients with 'refractory sprue'. JAMA 1989; 262:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/106\">",
"      Greenson JK, Giardiello FM, Lazenby AJ, et al. Antireticulin antibodies in collagenous and lymphocytic (microscopic) colitis. Mod Pathol 1990; 3:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/107\">",
"      McCashland TM, Donovan JP, Strobach RS, et al. Collagenous enterocolitis: a manifestation of gluten-sensitive enteropathy. J Clin Gastroenterol 1992; 15:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/108\">",
"      Perisic VN, Kokai G, Pavlovic M. Coeliac disease and collagenous colitis. Ital J Gastroenterol 1992; 24:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/109\">",
"      Freeman HJ. Collagenous colitis as the presenting feature of biopsy-defined celiac disease. J Clin Gastroenterol 2004; 38:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/110\">",
"      Freeman HJ, Davis JE, Myers DM. Complete histological resolution of collagenous sprue. Can J Gastroenterol 2004; 18:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/111\">",
"      Koskela RM, Karttunen TJ, Niemel&auml; SE, et al. Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis. Eur J Gastroenterol Hepatol 2008; 20:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/112\">",
"      Fine KD, Do K, Schulte K, et al. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol 2000; 95:1974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/113\">",
"      Tagkalidis PP, Gibson PR, Bhathal PS. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol 2007; 60:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/114\">",
"      Koskela RM, Niemel&auml; SE, Karttunen TJ, Lehtola JK. Clinical characteristics of collagenous and lymphocytic colitis. Scand J Gastroenterol 2004; 39:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/115\">",
"      Arora DS, Mahmood T, Wyatt JI. Lymphocytic venulitis: an unusual association with microscopic colitis. J Clin Pathol 1999; 52:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/116\">",
"      Castellano VM, Mu&ntilde;oz MT, Colina F, et al. Collagenous gastrobulbitis and collagenous colitis. Case report and review of the literature. Scand J Gastroenterol 1999; 34:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/117\">",
"      Chande N, McDonald JW, Macdonald JK. Interventions for treating lymphocytic colitis. Cochrane Database Syst Rev 2008; :CD006096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/118\">",
"      Chande N, McDonald JW, MacDonald JK. Interventions for treating collagenous colitis. Cochrane Database Syst Rev 2006; :CD003575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/119\">",
"      Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009; 104:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/120\">",
"      Beaugerie L, Pardi DS. Patients with drug-induced microscopic colitis should not be included in controlled trials assessing the efficacy of anti-inflammatory drugs in microscopic colitis. Gastroenterology 2009; 137:1535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/121\">",
"      Williams RA, Gelfand DV. Total proctocolectomy and ileal pouch anal anastomosis to successfully treat a patient with collagenous colitis. Am J Gastroenterol 2000; 95:2147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/122\">",
"      Miehlke S, Madisch A, Voss C, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005; 22:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/123\">",
"      Limsui D, Pardi DS, Camilleri M, et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007; 13:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/124\">",
"      Madisch A, Bethke B, Stolte M, Miehlke S. Is there an association of microscopic colitis and irritable bowel syndrome--a subgroup analysis of placebo-controlled trials. World J Gastroenterol 2005; 11:6409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/125\">",
"      Baert F, Schmit A, D'Haens G, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002; 122:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/126\">",
"      Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002; 123:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/127\">",
"      Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003; 52:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/128\">",
"      Madisch A, Heymer P, Voss C, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 2005; 20:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/129\">",
"      Miehlke S, Madisch A, Bethke B, Stolte M. Time to remission with budesonide in collagenous colitis. Aliment Pharmacol Ther 2005; 21:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/130\">",
"      Stewart MJ, Seow CH, Storr MA. Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2011; 9:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/131\">",
"      Vanderhoof JA, Goble K, Young RJ. Collagenous colitis in a 4-year-old child: response to budesonide. J Pediatr Gastroenterol Nutr 2010; 50:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/132\">",
"      Miehlke S, Madisch A, Karimi D, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 2009; 136:2092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/133\">",
"      Weidner N, Smith J, Pattee B. Sulfasalazine in treatment of collagenous colitis. Case report and review of the literature. Am J Med 1984; 77:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/134\">",
"      Calabrese C, Fabbri A, Areni A, et al. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol 2007; 22:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/135\">",
"      Zeroogian JM, Chopra S. Collagenous colitis and lymphocytic colitis. Annu Rev Med 1994; 45:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/136\">",
"      Sloth H, Bisgaard C, Grove A. Collagenous colitis: a prospective trial of prednisolone in six patients. J Intern Med 1991; 229:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/137\">",
"      Gentile NM, Abdalla AA, Khanna S, et al. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Am J Gastroenterol 2013; 108:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/138\">",
"      Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology 1998; 114:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/139\">",
"      Fine K, Ogunji F, Lee E, et al. Randomized, double-blind, placebo-controlled trial of bismuth subsalicylate for microscopic colitis (abstract). Gastroenterology 1999; 116:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/140\">",
"      Fisher NC, Tutt A, Sim E, et al. Collagenous colitis responsive to octreotide therapy. J Clin Gastroenterol 1996; 23:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/141\">",
"      Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001; 120:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/142\">",
"      Scheidler MD, Meiselman M. Use of verapamil for the symptomatic treatment of microscopic colitis. J Clin Gastroenterol 2001; 32:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/143\">",
"      Madisch A, Miehlke S, Eichele O, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int J Colorectal Dis 2007; 22:1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/144\">",
"      Esteve M, Mahadevan U, Sainz E, et al. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis 2011; 5:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/145\">",
"      M&uuml;nch A, Ignatova S, Str&ouml;m M. Adalimumab in budesonide and methotrexate refractory collagenous colitis. Scand J Gastroenterol 2012; 47:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/146\">",
"      J&auml;rnerot G, Tysk C, Bohr J, Eriksson S. Collagenous colitis and fecal stream diversion. Gastroenterology 1995; 109:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/56/27530/abstract/147\">",
"      Riaz AA, Pitt J, Stirling RW, et al. Restorative proctocolectomy for collagenous colitis. J R Soc Med 2000; 93:261.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4071 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-84581B2B62-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27530=[""].join("\n");
var outline_f26_56_27530=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Collagenous colitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Abnormal collagen metabolism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Bacterial toxins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - NSAIDs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Other drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2199622969\">",
"      - Smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Mechanism of diarrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL MANIFESTATIONS AND NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3268758125\">",
"      Collagenous colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3268758139\">",
"      Lymphocytic colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Stool examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Collagen band",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Intraepithelial lymphocytes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ASSOCIATION WITH SMALL BOWEL AND OTHER DISEASES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3268758146\">",
"      - Budesonide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3273552015\">",
"      - Aminosalicylate/sulfasalazine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3273552022\">",
"      - Cholestyramine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3268758153\">",
"      - Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3268758160\">",
"      - Bismuth subsalicylate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31688217\">",
"      - Other therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Natural history after medical treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4071\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4071|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/50/18208\" title=\"diagnostic image 1\">",
"      Collagenous colitis US",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4071|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/20/41288\" title=\"picture 1A\">",
"      Collagenous colitis Light I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/46/35561\" title=\"picture 1B\">",
"      Collagenous colitis Light II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/3/39993\" title=\"picture 2\">",
"      Lymphocytic colitis Light",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4071|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/35/36411\" title=\"table 1\">",
"      Collagenous v lymphocytic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=related_link\">",
"      Diagnosis of celiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26520?source=related_link\">",
"      Diagnosis of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/8/11400?source=related_link\">",
"      Diagnosis of the carcinoid syndrome and tumor localization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4714?source=related_link\">",
"      Management of celiac disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26406?source=related_link\">",
"      NSAIDs: Adverse effects on the distal small bowel and colon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/36/25154?source=related_link\">",
"      Patient information: Microscopic colitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20344?source=related_link\">",
"      Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/59/16311?source=related_link\">",
"      The VIPoma syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40169?source=related_link\">",
"      Treatment of irritable bowel syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_56_27531="Survival postsurgery PMP";
var content_f26_56_27531=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F72427&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F72427&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Survival after surgery for pseudomyxoma peritonei (PMP)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Institution",
"       </td>",
"       <td class=\"subtitle1\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\">",
"        Median survival, years",
"       </td>",
"       <td class=\"subtitle1\">",
"        Five-year survival, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        10-year survival, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mayo Clinic",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        5.9",
"       </td>",
"       <td>",
"        53",
"       </td>",
"       <td>",
"        32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sloan-Kettering",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        6.25",
"       </td>",
"       <td>",
"        75",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MD Anderson",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        54",
"       </td>",
"       <td>",
"        18",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PMP: pseudomyxoma peritonei.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <br>",
"       <ol>",
"        <li>",
"         Gough DB, et al. Ann Surg 1994; 219:112.",
"        </li>",
"        <li>",
"         Smith JW, et al. Cancer 1992; 70:396.",
"        </li>",
"        <li>",
"         Fernandez RN, et al. Arch Surg 1980; 115:409.",
"        </li>",
"       </ol>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27531=[""].join("\n");
var outline_f26_56_27531=null;
var title_f26_56_27532="ACC AHA prediction periop risk";
var content_f26_56_27532=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F62292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F62292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Clinical predictors of increased perioperative cardiovascular risk (myocardial infarction, heart failure, death)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Major predictors that require intensive management and may lead to delay in or cancellation of the operative procedure unless emergent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Unstable coronary syndromes including unstable or severe angina or recent MI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Decompensated heart failure including NYHA functional class IV or worsening or new-onset HF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Significant arrhythmias including high grade AV block, symptomatic ventricular arrhythmias, supraventricular arrhythmias with ventricular rate &gt;100 bpm at rest, symptomatic bradycardia, and newly recognized ventricular tachycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Severe heart valve disease including severe aortic stenosis or symptomatic mitral stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other clinical predictors that warrant careful assessment of current status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; History of ischemic heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; History of cerebrovascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; History of compensated heart failure or prior heart failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Renal insufficiency",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery); American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Vascular Surgery.",
"     <br>",
"      ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.",
"      <br>",
"       J Am Coll Cardiol. 2007 Oct 23;50(17):e159-241.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27532=[""].join("\n");
var outline_f26_56_27532=null;
var title_f26_56_27533="Rx staph endocarditis";
var content_f26_56_27533=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F81429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F81429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested regimens for therapy of native valve endocarditis due to staphylococcus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        American Heart Association",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        British Society for Antimicrobial Chemotherapy",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        European Society of Cardiology*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Adult (for patients with normal renal function)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Pediatric (not to exceed dose of normal adult)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        Oxacillin-susceptible strains",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle3\">",
"        Oxacillin-susceptible strains",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle3\">",
"        Methicillin-sensitive",
"       </td>",
"       <td class=\"subtitle3\">",
"        Methicillin-susceptible strains",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Nafcillin or oxacillin 12 g per 24 h IV in 4 or 6 equally divided doses for 6 wks,",
"         <strong>",
"          plus",
"         </strong>",
"         optional addition of&nbsp;gentamicin",
"         <sup>",
"          &sect;",
"         </sup>",
"         3 mg/kg per 24 h IV or IM in 2 or 3 equally divided doses for 3 to 5 days",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Cefazolin",
"         <sup>",
"          &loz;",
"         </sup>",
"         6 g per 24 h IV in 3 equally divided doses for 6 wks,",
"         <strong>",
"          plus",
"         </strong>",
"         optional addition of gentamicin",
"         <sup>",
"          &sect;",
"         </sup>",
"         3 mg/kg per 24 h IV or IM in 2 or 3 equally divided doses for 3 to 5 days",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Nafcillin or oxacillin 200 mg/kg per 24 h IV in 4 or 6 equally divided doses for 6 wks",
"         <strong>",
"          plus",
"         </strong>",
"         optional addition of gentamicin",
"         <sup>",
"          &sect;",
"         </sup>",
"         3 mg/kg per 24 h IV or IM in 3 equally divided doses for 3 to 5 days",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Cefazolin",
"         <sup>",
"          &loz;",
"         </sup>",
"         &nbsp;100 mg/kg per 24 h IV in 3 equally divided doses for 6 wks",
"         <strong>",
"          plus",
"         </strong>",
"         optional addition of&nbsp;gentamicin",
"         <sup>",
"          &sect;",
"         </sup>",
"         3 mg/kg per 24 h IV or IM in 3 equally divided doses for 3 to 5 days",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Flucloxacillin 2 g IV every 4 to 6 hours for 4 wks",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Oxacillin or cloxacillin or flucloxacillin 12 g per 24 h IV in 4-6 equally divided doses for 4 to 6 wks",
"         <strong>",
"          plus",
"         </strong>",
"         optional addition of gentamicin",
"         <sup>",
"          &sect;",
"         </sup>",
"         3 mg/kg per 24 h IV or IM divided in 2 or 3 doses for 3 to 5 days",
"        </p>",
"        <p>",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"        <p>",
"         Vancomycin",
"         <sup>",
"          &yen;",
"         </sup>",
"         30 mg/kg per 24 h IV in 2 equally divided doses for 4 to 6 wks",
"         <strong>",
"          plus",
"         </strong>",
"         optional addition of&nbsp;gentamicin",
"         <sup>",
"          &sect;",
"         </sup>",
"         3 mg/kg per 24 h IV or IM in 2 or 3 equally divided doses for 3 to 5 days",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        Oxacillin-resistant strains",
"       </td>",
"       <td class=\"subtitle3\">",
"        Oxacillin-resistant strains",
"       </td>",
"       <td class=\"subtitle3\">",
"        Methicillin resistant",
"       </td>",
"       <td class=\"subtitle3\">",
"        Methicillin resistant strains",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vancomycin 30 mg/kg per 24 h IV in 2 equally divided doses for 6 wks; not to exceed 2 g per 24 h unless concentrations in serum are inappropriately low",
"       </td>",
"       <td>",
"        Vancomycin 40 mg/kg per 24 h IV in 2 or 3 equally divided doses for 6 wks",
"       </td>",
"       <td>",
"        <p>",
"         Vancomycin 1 g IV every 12 h for 4 wks",
"        </p>",
"        <p>",
"         <strong>",
"          plus",
"         </strong>",
"        </p>",
"        <p>",
"         Rifampin 300 to 600 mg PO every 12 h for 4 wks",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"       </td>",
"       <td>",
"        Vancomycin 30 mg/kg per 24 h IV in 2 doses for 4 to 6 wks",
"        <strong>",
"         plus",
"        </strong>",
"        optional addition of&nbsp;gentamicin",
"        <sup>",
"         &sect;",
"        </sup>",
"        3 mg/kg per 24 h IV or IM in 2 or 3 equally divided doses for 3 to 5 days",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     h: hours; IV: intravenously; IM: intramuscularly; PO: orally; wks: weeks.",
"     <br>",
"      * Pediatric doses (should not exceed adult doses): oxacillin, cloxacillin, or flucloxacillin: 200 mg/kg per 24 h IV in 4 or 6 divided doses; gentamicin 3 mg/kg per 24 h IV or IM in 3 divided doses; vancomycin 40 mg/kg per 24 h IV in 2 or 3 divided doses.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       Aqueous penicillin G 24 million units/24 h IV in 4 to 6 equally divided doses may be used in place of nafcillin or oxacillin if strain is penicillin susceptible (MIC &le;0.1 &micro;g/mL) and does not produce &beta;-lactamase.",
"       <br>",
"        &Delta; Regimen for complicated right-sided and all left-sided IE.",
"        <br>",
"         <font class=\"lozenge\">",
"          &loz;",
"         </font>",
"         For penicillin-allergic, nonanaphylactoid type patients. Consider skin testing for questionable history of immediate-type hypersensitivty to &beta;-lactams; vancomycin should be used in these cases.",
"         <br>",
"          &sect; Clinical benefit of gentamicin not formally established. Use is associated with increased toxicity and is therefore optional.",
"          <br>",
"           &yen; Vancomycin therapy only recommended for patients allergic to penicillins.",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Circulation 2005; 111:3167; J Antimicrob Chemother 2012; 67:269; Eur Heart J 2009; 30:2369.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27533=[""].join("\n");
var outline_f26_56_27533=null;
var title_f26_56_27534="Warfarin and clotting proteins";
var content_f26_56_27534=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F50940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F50940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 572px\">",
"   <div class=\"ttl\">",
"    Effect of warfarin on blood clotting proteins",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 552px; height: 356px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The activity of various clotting proteins (logarithmic scale) is shown here as a function of time after ingestion of warfarin (10 mg/day PO for four consecutive days) by a normal subject. Factor VII activity, to which the prothrombin time is most sensitive, is the first to decrease. Full anticoagulation, however, does not occur until factors IX, X, and prothrombin are sufficiently reduced. Protein C activity falls quickly, and, in some patients, a transient hypercoagulable state may ensue (eg, coumarin necrosis).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Furie B. Oral anticoagulant therapy. In: Hematology: Basic Principles and Practice, 3rd ed, Hoffman R, Benz EJ, Shattil SJ, et al. (Eds), Churchill Livingstone, New York 2000. p.2040.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27534=[""].join("\n");
var outline_f26_56_27534=null;
var title_f26_56_27535="Stratte needle holder";
var content_f26_56_27535=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Double curved Stratte needle holder",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 263px; height: 453px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_56_27535=[""].join("\n");
var outline_f26_56_27535=null;
